Mood disorders, excluding more controls

KRA_PSY_MOOD_EXMORE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F30-F39 Hospital discharge: ICD-9 — 296\|3004A\|3011D Hospital discharge: ICD-8 — 296\|29800\|3004\|30110 Cause of death: ICD-10 — F30-F39 Cause of death: ICD-9 — 296\|3004A\|3011D Cause of death: ICD-8 — 296\|29800\|3004\|30110 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	KRA_PSY_MOOD_EXMORE
CONTROL_EXCLUDE	KRA_PSY_ANYMENTAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F3
HD_ICD_9	296\|3004A\|3011D
HD_ICD_8	296\|29800\|3004\|30110
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F3
COD_ICD_9	296\|3004A\|3011D
COD_ICD_8	296\|29800\|3004\|30110
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mood disorders, excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	68435	45643	22792
Unadjusted period prevalence (%)	13.72	15.56	10.05
Median age at first event (years)	40.20	38.33	43.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
31174: Matched controls
216444

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05BA04

ATC

oxazepam; oral

6.8

323.0

13050

20580

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

169.4

323.0

1730

F32.9

ICD-10 Finland

Depressive episode, unspecified

82.2

323.0

12472

1741

F41.1

ICD-10 Finland

Generalized anxiety disorder

35.7

323.0

2071

430

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

323.0

4727

11630

N05AL01

ATC

sulpiride; systemic

21.4

323.0

1011

338

N05BE01

ATC

buspirone; oral

21.7

323.0

2038

695

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

887.5

323.0

991

F33

ICD-10 Finland

Recurrent depressive disorder

28.2

323.0

751

189

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

688.4

323.0

962

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

323.0

434

F40.1

ICD-10 Finland

Social phobias

55.6

323.0

895

115

F41.00

ICD-10 Finland

Moderate panic disorder

141.1

323.0

618

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

323.0

503

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

97.8

323.0

1516

113

F32

ICD-10 Finland

Depressive episode

13.5

323.0

2741

1532

N05AB01

ATC

dixyrazine; systemic

21.8

323.0

786

257

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

632.5

323.0

713

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

+∞

323.0

667

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

+∞

323.0

522

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

262.2

323.0

412

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

323.0

1145

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

323.0

809

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

48.0

323.0

616

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

23.3

323.0

1471

459

N05AF01

ATC

flupentixol; systemic

16.7

323.0

1035

443

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

323.0

703

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

323.0

19939

108336

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1031.1

323.0

996

K02.1

ICD-10 Finland

Caries of dentine

1.7

323.0

15727

80060

N06AX18

ATC

reboxetine; oral

18.1

323.0

726

285

F10.25

ICD-10 Finland

Alcohol dependence continuous use

136.8

323.0

1121

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

323.0

11694

56031

L03

ICPC

Low back symptom/complaint

1.8

323.0

6757

28351

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

23.0

323.0

3731

1272

A04

ICPC

Weakness/tiredness general

2.6

323.0

3761

10885

AA1AD

NOMESCO Finland

CT of head and brain

2.2

323.0

7908

28876

F41.09

ICD-10 Finland

UNS Panic Syndrome

20.2

323.0

909

321

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

433.2

323.0

673

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

114.2

323.0

6518

500

WX290

NOMESCO Finland

Other blockade of nerve

1.7

323.0

11373

54295

N06AX05

ATC

trazodone; oral

17.3

323.0

1461

613

N06AB05

ATC

paroxetine; oral

9.1

323.0

3496

2970

N03AX09

ATC

lamotrigine; oral

22.4

323.0

2664

899

SPAT1243

SPAT

Psychiatric/psychological examination

13.4

323.0

914

488

N05BA06

ATC

lorazepam; systemic, sublingual

10.3

323.0

3011

2216

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.8

323.0

983

1030

N02BE01

ATC

paracetamol; systemic, rectal

1.9

323.0

25771

154686

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

49.5

323.0

914

132

F10.20

ICD-10 Finland

Alcohol dependence currently independent

151.5

323.0

1576

N06AA04

ATC

clomipramine; systemic

12.8

323.0

996

558

N05AD03

ATC

melperone; systemic

22.3

323.0

705

224

N07BB01

ATC

disulfiram; oral

15.1

323.0

2820

1416

M54.5

ICD-10 Finland

Low back pain

2.0

323.0

9825

40542

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

323.0

13682

67129

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

22.3

323.0

3481

1213

N05AA02

ATC

levomepromazine; systemic

36.8

323.0

3324

699

N05BA12

ATC

alprazolam; oral

6.0

323.0

5467

7463

N04AA02

ATC

biperiden; systemic

41.9

323.0

1086

186

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.7

323.0

4988

8460

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

323.0

8596

38960

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.3

323.0

1642

2754

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4267.7

323.0

610

SPAT1216

SPAT

Assessment of functional ability

2.1

323.0

4591

16614

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4513.2

323.0

644

N05AC02

ATC

thioridazine; oral

55.2

323.0

1200

157

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

226.0

323.0

484

N06AA06

ATC

trimipramine; systemic

10.9

323.0

1480

982

N05BA02

ATC

chlordiazepoxide; systemic

14.6

323.0

1509

753

N06AB10

ATC

escitalopram; oral

8.5

323.0

10497

12171

N05AX12

ATC

aripiprazole; systemic

318.4

323.0

2025

N06AA12

ATC

doxepin; systemic

8.5

323.0

3433

3119

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

156.0

323.0

465

F39

ICD-10 Finland

Unspecified mood [affective] disorder

91.3

323.0

907

WX110

NOMESCO Finland

Local anesthesy

1.7

323.0

19613

107833

N06AB03

ATC

fluoxetine; oral

8.9

323.0

7867

7901

P29

ICPC

Psychological sympt/compl other

13.3

323.0

2333

1312

R03AC02

ATC

salbutamol; inhalant

1.6

323.0

14632

75775

A02BC02

ATC

pantoprazole; systemic

1.8

323.0

19786

106454

P03

ICPC

Feeling depressed

10.7

323.0

3977

2927

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

308.9

323.0

995

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

152.7

323.0

604

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

1943.8

323.0

564

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.3

323.0

2020

4475

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

236.7

323.0

737

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

45.4

323.0

1379

220

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

698.2

323.0

2243

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1097.7

323.0

1626

KMAK

NOMESCO Finland

1.6

323.0

13885

71702

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

738.6

323.0

728

N06AX21

ATC

duloxetine; oral

7.8

323.0

6117

6544

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

323.0

7613

31054

N06AB04

ATC

citalopram; systemic

10.6

323.0

14181

15832

SPAT1240

SPAT

Therapeutic discussion

7.9

323.0

4548

4607

F99

ICD-10 Finland

Mental disorder, not otherwise specified

163.4

323.0

1025

SPAT1234

SPAT

Support of social functional capacity

4.4

323.0

1768

2917

F61.0

ICD-10 Finland

Mixed personality disorders

620.7

323.0

1205

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

15.6

323.0

676

307

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

165.7

323.0

1821

F32.8

ICD-10 Finland

Other depressive episodes

50.3

323.0

852

121

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6394.5

323.0

902

N06AB08

ATC

fluvoxamine; oral

12.1

323.0

1793

1087

N06AA09

ATC

amitriptyline; systemic

4.8

323.0

5154

8596

P72

ICPC

Schizophrenia

118.1

323.0

796

N03AF01

ATC

carbamazepine; oral, rectal

4.0

323.0

2043

3710

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

+∞

323.0

383

N05AF03

ATC

chlorprothixene; systemic

87.5

323.0

1929

163

N05AX08

ATC

risperidone; systemic

29.7

323.0

4555

1239

N06AX22

ATC

agomelatine; oral

23.7

323.0

1027

311

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

323.0

1619

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

323.0

443

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

108.7

323.0

2508

174

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

1685.9

323.0

492

F60.5

ICD-10 Finland

Anankastic personality disorder

137.0

323.0

600

N05AH03

ATC

olanzapine; systemic

98.3

323.0

4460

367

N05AD01

ATC

haloperidol; systemic

11.0

323.0

1420

933

EBA00

NOMESCO Finland

Extraction of tooth

1.9

323.0

9708

41502

N05AB03

ATC

perphenazine; systemic, rectal

45.7

323.0

2512

414

N06AX16

ATC

venlafaxine; oral

15.1

323.0

9759

6324

N06AX17

ATC

milnacipran; oral

17.5

323.0

648

262

A06AD11

ATC

lactulose; oral

2.8

323.0

5128

14244

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

323.0

7877

32922

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

323.0

2692

6626

A02BC01

ATC

omeprazole; systemic

1.8

323.0

8406

36980

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.2

323.0

1433

1996

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

323.0

10330

42221

P99

ICPC

Psychological disorders other

39.1

323.0

1442

268

F43.1

ICD-10 Finland

Post-traumatic stress disorder

27.8

323.0

641

163

P15

ICPC

Chronic alcohol abuse

18.6

323.0

1501

587

P16

ICPC

Acute alcohol abuse

17.2

323.0

725

299

SPAT1307

SPAT

Psychosocial counselling and guidance

8.5

323.0

1772

1516

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

323.0

4873

16395

P20

ICPC

Memory disturbance

2.4

323.0

3385

10493

A28

ICPC

Limited function/disability NOS

2.3

323.0

4503

14945

G47.3

ICD-10 Finland

Sleep apnoea

1.9

323.0

7174

29005

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

1215.4

323.0

1149

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

323.0

14652

76438

N06AX03

ATC

mianserin; oral

13.0

323.0

3591

2151

N06AB06

ATC

sertraline; oral

11.8

323.0

6572

4800

N05AN01

ATC

lithium; oral

137.2

323.0

2034

110

N03AX16

ATC

pregabalin; oral

2.6

323.0

8904

28377

P06

ICPC

Sleep disturbance

3.0

323.0

3134

7891

F10.09

ICD-10 Finland

Alcohol intoxication UNS

157.7

323.0

969

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.1

323.0

3274

6012

P74

ICPC

Anxiety disorder/anxiety state

14.7

323.0

1303

642

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

323.0

8949

37016

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

131.4

323.0

2919

170

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1335.8

323.0

1884

P01

ICPC

Feeling anxious/nervous/tense

9.0

323.0

3387

2885

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

53.6

323.0

591

V03AA01

ATC

15.3

323.0

1047

490

N06AX12

ATC

bupropion; oral

21.7

323.0

3426

1224

C07AA05

ATC

propranolol; systemic

3.0

323.0

6667

18041

N05BA01

ATC

diazepam; systemic, rectal

6.0

323.0

7376

10648

N06AX11

ATC

mirtazapine; oral

8.5

323.0

17962

29881

N05AF05

ATC

zuclopenthixol; systemic

230.8

323.0

494

A02BC03

ATC

lansoprazole; oral

1.8

323.0

9145

40952

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

323.0

15816

81916

N05AH04

ATC

quetiapine; oral

20.7

323.0

11291

5780

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2127.0

323.0

914

F34.1

ICD-10 Finland

Dysthymia

109.0

323.0

3101

219

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

323.0

402

P76

ICPC

Depressive disorder

18.6

323.0

3483

1451

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

323.0

6921

28691

F29

ICD-10 Finland

Unspecified nonorganic psychosis

322.6

323.0

1927

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

109.1

323.0

7509

628

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

9119

38507

N03AX12

ATC

gabapentin; oral

2.6

323.0

5592

16693

L28

ICPC

Limited function/disability (L)

2.2

323.0

4872

16840

F60.9

ICD-10 Finland

Personality disorder, unspecified

1345.5

323.0

784

N02AX02

ATC

tramadol; systemic, rectal

1.9

323.0

13762

64373

N05CF02

ATC

zolpidem; oral

3.1

323.0

6788

17834

N05CF01

ATC

zopiclone; oral

4.0

323.0

14635

39140

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2918.7

323.0

833

F43.29

ICD-10 Finland

Adaptation disorder UNS

21.1

323.0

638

214

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

17.4

323.0

4762

2223

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

255.5

323.0

581

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

323.0

369

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

331.4

323.0

4235

102

N06AG02

ATC

moclobemide; oral

10.8

323.0

3099

2190

N03AE01

ATC

clonazepam; systemic

6.4

323.0

2947

3489

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

323.0

436

IGY99

NOMESCO Finland

Other psychiatric treatment contact

208.2

323.0

729

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

1386.6

323.0

408

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3763.9

323.0

540

F31.8

ICD-10 Finland

Other bipolar affective disorders

557.2

323.0

1161

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

+∞

323.0

2314

F10.24

ICD-10 Finland

Alcohol depence active use

110.5

323.0

927

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

323.0

925

R42

ICD-10 Finland

Dizziness and giddiness

1.9

323.0

6490

26037

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

55.0

323.0

4226

615

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

323.0

9144

37761

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

231.4

323.0

6789

260

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

222.7

323.0

4384

159

IGY02

NOMESCO Finland

Psychiatric monitoring contact

198.8

323.0

1049

F33.8

ICD-10 Finland

Other recurrent depressive disorders

113.6

323.0

404

F41.8

ICD-10 Finland

Other specified anxiety disorders

14.5

323.0

688

336

T36

ICD-10 Finland

Poisoning by systemic antibiotics

73.4

323.0

3040

318

F32.1

ICD-10 Finland

Moderate depressive episode

29.7

323.0

3340

871

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

323.0

2712

6853

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

252.8

323.0

1164

R06.0

ICD-10 Finland

Dyspnoea

1.9

323.0

7610

31669

F03

ICD-10 Finland

Unspecified dementia

11.1

323.0

948

611

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

538.7

323.0

1410

AA400

NOMESCO Finland

Electroconvulsive therapy

1366.4

323.0

600

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

278.3

323.0

670

R53

ICD-10 Finland

Malaise and fatigue

3.0

323.0

6968

18982

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1295.5

323.0

704

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

323.0

4744

15506

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

47.8

323.0

3384

550

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

398.5

323.0

565

S06.0

ICD-10 Finland

Concussion

2.7

323.0

3113

8437

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5522.8

323.0

783

F32.0

ICD-10 Finland

Mild depressive episode

11.7

323.0

1094

672

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

1563.6

323.0

1122

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.3

323.0

2292

5120

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

168.8

323.0

1461

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

323.0

414

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

1303.8

323.0

761

F51.0

ICD-10 Finland

Nonorganic insomnia

4.3

323.0

4540

8282

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

323.0

493

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

972.9

323.0

547

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

33.1

323.0

801

172

N05AH02

ATC

clozapine; systemic

755.2

323.0

744

N03AG01

ATC

valproic acid; systemic, rectal

16.2

323.0

3866

1877

N06AX26

ATC

vortioxetine; oral

14.6

323.0

2913

1515

N05AA01

ATC

chlorpromazine; systemic, rectal

104.6

323.0

836

R51.80

ICD-10 Finland

Headache

2.6

323.0

4124

12197

N05CD07

ATC

temazepam; oral

6.0

323.0

7397

10633

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

260.6

323.0

737

M79.6

ICD-10 Finland

Pain in limb

1.8

323.0

10243

47236

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

323.0

421

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

156.0

323.0

1189

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

323.0

536

F22.0

ICD-10 Finland

Delusional disorder

147.4

323.0

787

SPAT1254

SPAT

Administration of medicine

2.3

323.0

4442

14525

F31

ICD-10 Finland

Bipolar affective disorder

224.9

323.0

826

SPAT1246

SPAT

Screening of depression or other psychiatric problem

6.5

321.2

949

1046

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

315.6

17169

94303

F60.8

ICD-10 Finland

Other specific personality disorders

629.6

315.2

359

J01DA01

ATC

[U] cefalexin; systemic

1.6

312.7

17822

98925

A02BA02

ATC

ranitidine; systemic

1.9

312.6

6206

25543

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

310.5

4768

17832

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

309.4

343

M79.7

ICD-10 Finland

Fibromyalgia

5.5

309.0

1043

1365

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

314.0

308.4

359

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

70.7

307.9

402

Z71.8

ICD-10 Finland

Other specified counselling

1.8

305.8

6175

25540

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

79.8

300.1

386

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

+∞

299.4

332

A02BC05

ATC

esomeprazole; systemic

1.6

298.5

11894

60052

Z72.1

ICD-10 Finland

Alcohol use

14.9

297.2

560

266

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

296.8

4308

15719

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

475.0

295.5

339

H03AA01

ATC

levothyroxine sodium; systemic

1.8

294.4

6521

27767

XA800

NOMESCO Finland

Neuropsychological investigation

3.9

293.7

1364

2487

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

293.6

15523

83980

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

120.0

290.8

359

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

289.8

5076

19909

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

89.1

289.7

368

30180

ICD-8 Finland

Personality disorders, Immatura

+∞

289.5

321

G44.2

ICD-10 Finland

Tension-type headache

2.2

289.0

3435

11482

F60.7

ICD-10 Finland

Dependent personality disorder

764.1

288.3

327

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.7

288.1

1440

2799

F90.0

ICD-10 Finland

Disturbance of activity and attention

23.2

286.5

465

141

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

286.4

13093

68204

N05CD02

ATC

nitrazepam; oral

6.7

286.3

827

882

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

28.3

279.9

431

107

SPAT1301

SPAT

No procedures

1.7

279.6

8911

42200

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

277.7

308

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

277.4

3995

14498

F05.9

ICD-10 Finland

Delirium, unspecified

7.7

276.3

721

660

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

2117.8

276.2

309

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

276.1

4968

19638

A01

ICPC

Pain general/multiple sites

2.6

276.0

2318

6470

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

+∞

275.9

306

G30.1

ICD-10 Finland

Alzheimer disease with late onset

6.0

274.3

852

1003

F61

ICD-10 Finland

Mixed and other personality disorders

225.8

274.2

324

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

273.2

6180

26401

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

2068.3

269.9

302

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

269.8

8407

39482

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

10.9

269.2

580

375

R41.0

ICD-10 Finland

Disorientation, unspecified

5.0

268.8

969

1367

N06DX01

ATC

memantine; oral

4.9

268.1

990

1435

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

20.3

266.5

450

156

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

265.6

11492

58706

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

265.5

3083

10169

F21

ICD-10 Finland

Schizotypal disorder

1066.0

265.1

299

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

702.7

264.9

301

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

263.0

4356

16670

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

262.2

3829

13947

-1

NOMESCO Finland

1.6

261.8

8509

40353

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

261.8

10756

54196

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

+∞

260.6

289

30188

ICD-8 Finland

Personality disorders, Alia definita

+∞

260.6

289

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

259.3

7204

32679

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.4

259.2

1439

3041

N06AA22

ATC

18.9

259.0

447

166

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

257.3

2511

7597

C07AB07

ATC

bisoprolol; oral

1.5

256.2

14124

76168

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

256.1

5012

20348

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

255.9

5471

22883

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

253.9

7061

32006

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

253.7

4414

17183

N06BA04

ATC

methylphenidate; oral

18.3

253.1

442

170

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

13.2

253.1

500

267

SPAT1263

SPAT

Sampling

1.5

252.7

11596

59861

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

152.7

251.8

305

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

251.0

13160

70038

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

1913.0

250.0

280

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

+∞

248.8

276

P01AB01

ATC

metronidazole; oral, rectal

1.6

248.0

10439

52716

R11

ICD-10 Finland

Nausea and vomiting

2.5

245.2

2149

6128

L17

ICPC

Foot/toe symptom/complaint

1.7

244.8

7015

32014

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

243.6

2001

5500

C03CA01

ATC

furosemide; systemic

1.6

242.8

8247

39405

P27

ICPC

Fear of mental disorder

19.5

240.5

411

148

K59.0

ICD-10 Finland

Constipation

2.9

239.3

1703

4285

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

238.4

5138

21486

R03BB04

ATC

tiotropium bromide; inhalant

2.1

237.7

3039

10436

M25.5

ICD-10 Finland

Pain in joint

1.6

236.3

7482

35039

P28

ICPC

Limited function/disability (P)

32.5

236.3

352

J02AC01

ATC

fluconazole; systemic

1.6

234.0

9284

46046

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

216.9

233.8

277

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

233.1

11014

56923

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

232.0

2961

10156

N02AA05

ATC

oxycodone; systemic

1.9

231.5

4227

16691

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

1764.9

231.1

259

J01DB01

ATC

cefalexin; oral

1.5

229.9

23402

142879

P73

ICPC

Affective psychosis

267.8

229.6

269

P98

ICPC

Psychosis NOS/other

210.4

226.6

269

R52.2

ICD-10 Finland

Other chronic pain

3.8

226.5

1095

2062

F41.3

ICD-10 Finland

Other mixed anxiety disorders

29.5

226.5

345

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

226.3

2366

7391

E66.8

ICD-10 Finland

Other obesity

3.2

225.2

1378

3126

F20.0

ICD-10 Finland

Paranoid schizophrenia

1694.5

222.1

249

F43.00

ICD-10 Finland

Acute stress reaction mild

7.7

221.7

579

530

SPAT1265

SPAT

Breathalyser

14.4

220.5

420

205

IGV01

NOMESCO Finland

Psychiatric network contact

1680.4

220.3

247

WZA90

NOMESCO Finland

Other doctors statement

1.7

220.0

6102

27460

N06AA10

ATC

nortriptyline; systemic

5.1

219.9

781

1082

N05BA05

ATC

potassium clorazepate; oral

10.3

219.9

488

335

29800

ICD-8 Finland

Other psychoses, Reactive depressive psychosis

+∞

218.1

242

R07.3

ICD-10 Finland

Other chest pain

2.1

217.7

2791

9578

P25

ICPC

Phase of life problem adult

4.3

217.6

914

1512

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

217.2

4729

19772

M03BX02

ATC

tizanidine; oral

1.5

217.2

17142

98350

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

253.7

217.1

255

R02

ICPC

Shortness of breath/dyspnoea

2.0

217.0

3382

12569

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

575.4

216.4

247

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.8

215.2

1044

1971

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

214.8

9787

49904

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

213.5

8165

39932

S01.0

ICD-10 Finland

Open wound of scalp

2.3

212.5

2164

6663

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

212.3

3176

11612

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

835.4

211.1

239

D11

ICPC

Diarrhoea

2.2

210.3

2546

8510

N30.0

ICD-10 Finland

Acute cystitis

2.0

210.2

3379

12697

N05AE04

ATC

ziprasidone; systemic

422.4

210.2

242

IHZ05

SPAT

12.5

210.1

424

238

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

210.1

9512

48373

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

+∞

210.0

233

30088

ICD-8 Finland

Neuroses, Other

+∞

210.0

233

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

209.1

232

UJF32

NOMESCO Finland

Coloscopy

1.6

208.5

7490

36027

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

208.3

1799

5074

T90

ICPC

Diabetes non-insulin dependent

1.6

207.7

6903

32546

R52.9

ICD-10 Finland

Pain, unspecified

2.2

207.0

2358

7664

N03AX11

ATC

topiramate; oral

5.9

206.7

655

790

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

206.7

7258

34697

SPAT1310

SPAT

Counselling related to known health issue

1.5

206.6

8619

42968

A10BA02

ATC

metformin; oral

1.6

205.6

8153

40146

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

9.3

205.6

480

363

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

204.8

7939

38876

F20

ICD-10 Finland

Schizophrenia

544.8

204.7

234

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

204.0

5987

27286

F30.9

ICD-10 Finland

Manic episode, unspecified

807.2

203.9

231

Z08

ICPC

Social welfare problem

9.3

203.4

474

357

SPAT1241

SPAT

Extensive assessment of psychosocial situation

16.8

202.7

364

152

F20.5

ICD-10 Finland

Residual schizophrenia

+∞

201.9

224

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

201.2

7128

34111

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

200.9

4461

18722

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

21.4

200.8

333

109

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

199.9

2080

6467

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

199.5

3224

12123

29999

ICD-8 Finland

Unspecified psychosis

+∞

198.3

220

29580

ICD-8 Finland

Schizophrenia, Other

+∞

196.5

218

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

+∞

196.5

218

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

196.2

1905

5719

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

196.1

2791

9983

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

195.8

3489

13591

K08.3

ICD-10 Finland

Retained dental root

2.3

195.6

2108

6666

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

195.3

11944

64513

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

164.3

195.1

235

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

195.0

2779

9943

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

181.3

194.7

233

R06AE07

ATC

cetirizine; oral

1.5

194.4

10972

58271

F60.0

ICD-10 Finland

Paranoid personality disorder

768.5

194.0

220

J01FF01

ATC

clindamycin; systemic

1.6

193.4

7438

36256

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

1469.4

193.3

217

SPAT1229

SPAT

Assessment of need for aid

2.2

192.5

2293

7594

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

+∞

190.1

211

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

+∞

189.2

210

N01

ICPC

Headache

2.3

188.9

2057

6532

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

305.1

188.0

219

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

27.4

187.2

290

SPAT1260

SPAT

Consultation of another employee

1.7

187.2

4860

21334

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

186.5

1647

4697

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

186.4

4458

19097

N07BA03

ATC

varenicline; oral

2.7

186.4

1416

3700

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

8.4

186.2

462

389

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

114.9

185.8

230

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

185.2

5964

27760

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

185.0

8737

44548

L01

ICPC

Neck symptom/complaint

1.9

184.7

3432

13548

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.6

184.0

925

1798

P58

ICPC

Psychological, Therapeutic counselling/listening

9.6

183.9

423

311

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

+∞

181.1

201

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

+∞

181.1

201

N06DA02

ATC

donepezil; oral

3.9

180.7

829

1488

Z01.2

ICD-10 Finland

Dental examination

1.5

180.6

10302

54599

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

180.2

200

29599

ICD-8 Finland

Schizophrenia, Unspecified type

+∞

179.3

199

SPAT1053

SPAT

Memory test

1.8

179.1

3950

16485

E0000UV

ATC

1.5

179.0

10014

52836

IBA03

NOMESCO Finland

Psychotherapy evaluation

708.6

178.7

203

H02AB06

ATC

prednisolone; systemic

1.4

178.7

12821

71044

W19

ICD-10 Finland

Unspecified fall

2.0

177.9

2482

8787

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

177.6

3280

12907

Z73.0

ICD-10 Finland

Burn-out

5.1

177.6

633

880

R4140

NOMESCO Finland

Psychotherapy

57.4

177.5

238

X78

ICD-10 Finland

Intentional self-harm by sharp object

+∞

176.6

196

SPAT1227

SPAT

Substance abuse rehabilitation

21.2

176.1

293

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

175.7

1894

5979

N05AC01

ATC

periciazine; systemic

30.0

175.6

266

L02

ICPC

Back symptom/complaint

2.1

175.1

2217

7532

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

174.8

7324

36260

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

465.0

174.3

200

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.7

171.4

414

333

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

94.4

171.3

216

IEY01

NOMESCO Finland

Psychoeducation, individual

278.3

171.0

200

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.6

170.8

1452

4049

J01EA01

ATC

trimethoprim; systemic

1.6

170.6

6041

28712

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

170.5

1834

5780

B18.2

ICD-10 Finland

Chronic viral hepatitis C

13.3

170.4

335

177

SPAT1238

SPAT

Brief therapy

7.0

169.9

472

475

P18

ICPC

Medication abuse

41.9

169.9

240

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

1286.9

169.9

191

A02BA04

ATC

nizatidine; systemic

2.0

168.5

2361

8364

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

274.0

168.4

197

A03FA02

ATC

cisapride; oral, rectal

2.1

168.1

2289

8014

V03AB30

ATC

10.6

167.8

365

241

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

167.4

4542

20121

IGY02

SPAT

31.3

167.4

251

N03AF02

ATC

oxcarbazepine; oral

3.4

167.2

909

1882

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

166.9

2341

8296

F45.0

ICD-10 Finland

Somatization disorder

61.8

166.6

221

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.9

166.0

1160

2872

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

128.9

165.6

203

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

55.7

165.6

223

N05AX13

ATC

paliperidone; systemic

+∞

164.9

183

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

+∞

164.9

183

J01CA08

ATC

pivmecillinam; oral

1.5

164.3

8438

43553

Z00.0

ICD-10 Finland

General medical examination

1.6

164.2

4800

21689

P80

ICPC

Personality disorder

85.9

164.1

209

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

164.0

4784

21604

SPAT1252

SPAT

Overall medication plan or its review

2.2

164.0

1979

6577

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

163.7

2001

6689

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

163.3

8936

46716

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.5

163.2

1416

3992

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

162.7

3527

14605

SPAT1235

SPAT

Mental health, emotional support

19.6

162.6

277

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

162.5

9964

53264

F41.01

ICD-10 Finland

Severe panic disorder

169.4

161.5

194

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

161.4

5963

28581

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

161.2

1614

4908

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

161.0

3228

13032

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

1216.9

160.9

181

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6.1

160.1

493

573

R74

ICPC

Upper respiratory infection acute

1.6

159.8

5785

27579

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.6

159.7

1365

3815

TAB00

NOMESCO Finland

Lumbar puncture

2.9

159.4

1113

2754

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

159.2

1282

3463

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

159.0

5087

23515

N06DA03

ATC

rivastigmine; oral, transdermal

4.8

157.4

584

849

D01

ICPC

Abdominal pain/cramps general

1.9

157.2

2471

9149

R1250

NOMESCO Finland

Evaluation of functional capability

4.1

157.2

684

1169

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

6.3

157.0

467

518

F34.0

ICD-10 Finland

Cyclothymia

255.7

156.8

184

2961A

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]

+∞

156.8

174

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

+∞

156.8

174

M01AE02

ATC

naproxen; oral, rectal

1.4

156.4

14955

86478

N04BC05

ATC

pramipexole; oral

2.1

155.4

2115

7395

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

+∞

155.0

172

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

+∞

155.0

172

J01FA06

ATC

roxithromycin; oral

1.4

154.9

10726

58529

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.7

154.9

1183

3096

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

154.8

3138

12701

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.1

154.7

1919

6450

T74.1

ICD-10 Finland

Physical abuse

6.7

154.4

442

465

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

154.3

3694

15746

R25.1

ICD-10 Finland

Tremor, unspecified

3.2

154.3

904

1980

R55

ICD-10 Finland

Syncope and collapse

1.8

153.9

2851

11198

F30.0

ICD-10 Finland

Hypomania

311.4

153.8

179

A01AB09

ATC

miconazole; local oral

1.9

153.2

2412

8931

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

152.4

3737

16039

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

89.9

152.3

193

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

1233.2

151.9

171

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

151.5

1805

5957

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

1225.1

151.0

170

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

13.3

150.8

296

156

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

+∞

150.4

167

G72.8

ICD-10 Finland

Other specified myopathies

5.6

150.3

489

610

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

150.1

2674

10352

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

+∞

149.5

166

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

149.3

2876

11437

IGP01

NOMESCO Finland

Psychiatric family contact

116.8

149.0

184

R4110

NOMESCO Finland

Physiotherapy

1.5

148.3

7187

36493

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

589.1

148.2

169

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.0

148.1

538

764

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

+∞

147.7

164

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

147.7

164

M79.1

ICD-10 Finland

Myalgia

1.8

147.1

2991

12109

R41.3

ICD-10 Finland

Other amnesia

3.4

146.6

798

1653

IER01

NOMESCO Finland

Psychoeducation, group

1184.8

146.5

165

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

67.1

146.4

192

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

146.2

2536

9724

N05CD08

ATC

midazolam; nasal, systemic

3.5

146.0

757

1508

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

91.8

145.6

184

J01AA02

ATC

doxycycline; systemic

1.4

144.3

22340

139279

EBA30

NOMESCO Finland

Excision of root of tooth

2.3

144.1

1565

4945

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

143.2

2785

11103

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

143.1

3357

14199

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(36660697) Celiac disease serology panel - Serum

6113

21896

1.78

320.65

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10009

40905

1.59

319.77

3.1

2.8

3.9

2.8

e6/l

9.06

5159

22016

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2061

4792

2.67

319.06

1.2

1.3

3.8

3.7

mmol/l

5.31

1922

4519

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2724

7259

2.34

319.01

1.9

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11473

48413

1.55

318.90

4.0

3.4

260.9

599.9

ng/l

14.62

7803

36112

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11490

48517

1.55

318.35

1.3

30.6

35.4

iu/ml

1.62

3089

15812

(40761511) CBC panel - Blood by Automated count

54348

309295

1.74

312.80

16.2

11.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

27583

108328

2.02

307.65

2.5

2.2

3333.5

77.4

nmol/l

0.50

25156

98478

(3023103) Potassium [Moles/volume] in Serum or Plasma

54933

293567

2.65

307.65

19.4

13.5

3.9

4.0

mmol/l

67.84

53712

285272

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9556

36660

1.70

307.65

2.6

2.5

2.4

g/l

12.43

8670

34179

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2081

4798

2.70

307.65

1.4

30.1

34.4

e6/l

0.20

1597

3716

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10371

33111

2.09

307.65

2.3

1.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8173

21610

2.51

307.65

2.0

2.3

370.7

375.5

nmol/l

1.15

7407

20109

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6294

21198

1.90

307.65

4.2

3.8

5.9

5.8

kpa

11.53

6043

20668

(3032080) INR in Blood by Coagulation assay

22397

103502

1.51

307.65

8.1

8.2

1.2

inr

21.99

6749

30419

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11212

36997

2.04

307.65

2.4

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4501

14430

1.97

307.65

3.6

3.3

5.2

5.1

kpa

13.91

4215

13316

(3028300) Cannabinoids [Presence] in Urine

6267

9480

4.37

307.65

3.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

4661

1066

28.76

307.65

3.2

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14199

59364

1.60

307.65

1.9

1.7

1.1

1.2

mg/l

2.67

10490

45220

(3014111) Lactate [Moles/volume] in Serum or Plasma

6122

20309

1.93

307.65

7.0

7.2

1.4

1.3

mmol/l

6.21

5829

19673

(1001926) Buprenorphine [Presence] in Urine by Screen method

5584

6167

5.97

307.65

3.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

13937

54025

1.74

307.65

1.5

1.4

2.3

2.4

g/l

1.18

7818

34465

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8791

34096

1.67

307.65

2.7

2.5

22.1

23.2

10.03

7511

29354

(3015377) Calcium [Moles/volume] in Serum or Plasma

23083

82490

2.14

307.65

2.9

3.5

2.4

mmol/l

2.29

20292

72620

(3031040) Bacteria [#/volume] in Urine by Automated count

38452

181178

1.81

307.65

5.3

3.9

1654.3

1126.3

e6/l

0.92

542

2339

(3023511) Choriogonadotropin [Units/volume] in Urine

2329

5227

2.78

307.65

1.4

1.3

—

(3002032) Base excess in Venous blood by calculation

6282

21158

1.90

307.65

4.2

3.8

1.9

1.8

mmol/l

1.23

5124

17411

(3033658) Prothrombin time (PT) actual/Normal

16217

66837

1.65

307.65

4.5

3.7

94.0

90.9

42.88

15703

65271

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6531

22250

1.88

307.65

2.4

2.3

0.2

g/l

3.79

5929

20961

(3024561) Albumin [Mass/volume] in Serum or Plasma

27627

109080

2.00

307.65

4.9

4.8

36.1

35.8

g/l

7.80

25565

101583

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17273

61759

1.99

307.65

2.4

2.2

2.9

mg/l

0.84

14744

53191

(3012544) pH of Venous blood

6447

22072

1.87

307.65

4.2

3.9

7.4

0.32

117

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9210

31040

1.95

307.65

6.0

1.0

mmol/l

0.69

8585

29083

(3009508) Creatinine [Moles/volume] in Urine

19966

80820

1.75

307.65

3.5

3.1

7.7

7.8

mmol/l

1.50

16822

68586

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

16252

62219

1.81

307.65

1.3

1.4

1.8

u/ml

3.59

4091

17597

(3016879) Cocaine [Presence] in Urine

6062

8360

4.80

307.65

3.0

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

5219

17173

1.93

307.65

3.6

3.1

4.8

4.6

kpa

7.25

4980

16680

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10740

43910

1.59

307.65

2.9

2.6

1.2

1.1

e6/l

0.33

5859

24865

(3030467) Casts [#/volume] in Urine by Automated count

17265

71621

1.66

307.65

3.4

3.0

0.4

e6/l

1.42

13028

53052

(3006504) Eosinophils/100 leukocytes in Blood

29226

128956

1.74

307.65

6.7

5.8

2.8

2.9

12.95

27185

120729

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

891

449

12.24

307.65

2.5

1.3

159.2

75.6

umol/l

7.90

462

212

(3021960) Folate [Moles/volume] in Serum or Plasma

16424

53092

2.21

307.65

1.6

1.5

20.0

20.5

nmol/l

3.92

14482

45358

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

52452

262419

2.73

307.65

6.1

4.3

1.9

2.1

mu/l

2.01

49196

242140

(3002030) Lymphocytes/100 leukocytes in Blood

29923

134338

1.71

307.65

6.8

5.8

28.7

28.4

6.60

27815

125847

(3026008) Bacteria identified in Urine by Culture

18334

75371

1.69

307.65

3.4

2.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

39478

193662

1.70

307.65

4.9

3.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2299

5500

2.60

307.65

1.3

504.0

547.7

mg/l

1.15

2185

5281

(3018418) pH of Serum or Plasma

19855

72238

2.01

307.65

4.2

4.1

7.4

2.46

3530

14000

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

32600

135617

2.01

307.65

6.0

10.1

11.4

umol/l

70.56

30563

128796

(3013650) Neutrophils [#/volume] in Blood by Automated count

35652

158461

1.91

307.65

10.5

8.2

4.2

4.0

e9/l

19.99

31119

138874

(3023368) Bacteria identified in Blood by Culture

16352

65615

1.71

307.65

4.8

4.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7260

22853

2.06

307.65

2.9

2.4

40.4

48.1

u/l

0.49

6144

19682

(3013826) Glucose [Moles/volume] in Serum or Plasma

34637

156090

1.83

307.65

5.5

4.3

6.6

6.7

mmol/l

0.06

32379

144207

(3000850) Epithelial cells [#/volume] in Urine

13345

53722

1.66

307.65

2.8

2.5

6.7

5.4

e6/l

16.30

11681

46714

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

10426

38183

1.80

307.65

2.0

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

3776

9889

2.41

307.65

1.7

1.6

368.1

274.2

mu/l

20.84

3340

9020

(3002582) Erythrocytes [#/volume] in Urine

18560

78617

1.63

307.65

3.5

3.0

55.8

95.2

e6/l

4.74

14237

59545

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

27542

99551

2.26

307.65

2.1

1.8

96.9

pmol/l

0.03

14924

51820

(3015736) pH of Urine

24003

104656

1.66

307.65

3.8

3.1

5.9

5.7

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

858

661.57

307.65

2.3

1.4

144.1

110.9

nmol/l

—

743

(3017143) Hepatitis C virus Ab [Presence] in Serum

9480

33916

1.83

307.65

1.8

1.6

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

2060

381.68

307.65

12.2

5.2

0.6

mmol/l

0.61

1908

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4316

13721

1.98

307.65

3.5

3.3

1.6

mmol/l

0.10

3257

10004

(3022096) Basophils/100 leukocytes in Blood

28412

124845

1.73

307.65

6.7

5.8

0.7

3.09

26418

116969

(3001122) Ferritin [Mass/volume] in Serum or Plasma

28980

122729

1.85

307.65

3.2

2.7

105.3

120.3

ug/l

15.74

26784

114972

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

19783

73865

1.94

307.65

2.4

2.0

231.1

191.5

u/l

3.53

18584

69288

(4198724)

1249

204

38.02

307.65

2.4

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

14607

58633

1.68

307.65

2.1

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

14651

62205

1.57

307.65

4.0

3.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

55228

311830

1.98

307.65

19.1

13.8

74.6

76.4

umol/l

27.04

55219

311653

(40758558) Short blood count panel - Blood

16691

66612

1.73

307.65

7.4

6.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

53635

293109

2.08

307.65

17.5

11.9

21.2

23.2

mg/l

37.33

44130

226578

(3013707) Erythrocyte sedimentation rate by Westergren method

42976

207512

1.92

307.65

4.4

3.9

11.6

11.2

mm/h

5.20

39868

193180

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

45751

209048

2.40

307.65

8.1

7.2

77.2

76.9

u/l

0.68

43250

197176

(3019198) Lymphocytes [#/volume] in Blood

32382

141461

1.85

307.65

6.7

5.6

2.0

1.9

e9/l

7.13

28485

125600

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5224

16527

2.01

307.65

2.1

1.8

—

(3001604) Monocytes [#/volume] in Blood

31698

136453

1.88

307.65

6.6

5.6

0.6

e9/l

1.21

27396

118949

(3013115) Eosinophils [#/volume] in Blood

32625

141816

1.88

307.65

7.1

5.7

0.2

e9/l

0.57

28654

125438

(3000991) Gas panel - Venous blood

5717

19759

1.84

307.65

8.6

8.5

—

(3009343) pH of Capillary blood

4446

14237

1.97

307.65

3.6

3.3

7.4

0.74

569

1907

(3003396) Base excess in Arterial blood by calculation

7225

26719

1.73

307.65

7.7

7.3

1.2

0.9

mmol/l

4.32

5733

21006

(3037522) Nuclear Ab [Titer] in Serum

9576

37913

1.64

307.65

1.4

1.3

480.7

573.5

titre

4.54

1761

7822

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

29350

111160

2.19

307.65

6.3

5.8

1.2

mmol/l

0.56

26882

100675

(3014576) Chloride [Moles/volume] in Serum or Plasma

8023

30208

1.71

307.65

7.5

7.0

104.1

104.6

mmol/l

15.38

7846

29600

(3018095) Leukocytes [#/volume] in Urine

21745

93539

1.65

307.65

4.1

3.4

76.7

92.7

e6/l

2.12

15283

64767

(42870588) Differential panel, method unspecified - Blood

22250

90983

1.78

307.65

6.1

5.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2772

3452

5.07

307.65

1.5

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

14237

38744

2.62

307.65

1.8

1.7

1171.7

1158.1

nmol/l

0.86

11087

29351

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1293

922

8.70

307.65

1.7

1.1

1.5

0.9

promille

18.62

969

737

(3009261) Glucose [Presence] in Urine by Test strip

28563

140230

1.46

307.65

4.2

3.3

0.0

estimate

0.09

5504

25528

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8197

29045

1.83

307.65

2.7

7.3

8.3

umol/l

4.04

6732

25572

(3027801) Oxygen [Partial pressure] in Arterial blood

7240

26716

1.74

307.65

7.7

7.3

11.9

12.9

kpa

41.19

6929

25490

(3018010) Neutrophils/100 leukocytes in Blood

29559

132321

1.71

307.65

6.6

5.6

56.7

56.9

2.18

27557

124515

(3022948) Iron [Moles/volume] in Serum or Plasma

10385

39861

1.71

307.65

2.6

2.5

13.3

14.0

umol/l

0.82

9537

37190

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14013

50831

1.88

307.65

1.7

1.6

32441851.9

41087014.7

pmol/l

0.86

11735

42537

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

47733

216611

2.67

307.65

5.0

3.7

14.4

14.7

pmol/l

138.28

44134

197947

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5199

17236

1.91

307.65

1.7

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24400

86106

2.22

307.65

3.7

3.0

32.5

32.9

u/l

0.23

22925

82040

(3006315) Basophils [#/volume] in Blood

31845

137056

1.88

307.65

6.6

5.6

0.0

e9/l

2.55

27489

119442

(3019069) Monocytes/100 leukocytes in Blood

29379

129662

1.74

307.65

7.0

6.0

8.3

8.6

36.63

27459

122072

(3007853) Bacteria identified in Skin by Aerobe culture

8299

30323

1.77

307.65

1.9

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

28434

138118

1.48

307.65

4.1

3.3

0.0

estimate

2.75

5520

25606

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

41696

193735

2.02

307.65

4.2

2.6

50.8

43.8

u/l

33.91

39117

182419

(3009466) Valproate [Moles/volume] in Serum or Plasma

3155

1027

19.67

307.65

6.1

2.7

374.0

356.9

umol/l

2.89

2792

845

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7241

26733

1.74

307.65

7.7

7.3

5.2

5.1

kpa

13.41

6933

25510

(3027944) Amphetamines [Presence] in Urine

6031

9455

4.20

307.65

2.8

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

51414

276598

1.92

307.65

5.1

4.1

6.0

5.8

mmol/l

105.29

47588

255112

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

31762

123906

2.19

307.65

7.0

6.5

1.2

mmol/l

0.36

27100

104362

(3048689) Calprotectin [Mass/mass] in Stool

9480

34507

1.80

307.65

2.2

2.5

117.3

134.6

ug/g

5.17

7246

27547

(3011288) Drugs identified in Urine by Screen method

5472

4374

8.27

307.65

3.9

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

11184

39078

1.91

307.65

3.4

0.8

mmol/l

5.82

10383

36628

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7324

25521

1.85

307.65

1.9

1.6

—

(36304419) Bacteria [Presence] in Urine

16924

70137

1.65

307.65

3.4

2.9

—

(3042517) Benzodiazepines panel - Urine

389

183.23

307.65

2.9

1.8

—

(3021589) Normoblasts [#/volume] in Blood

26886

123826

1.58

307.65

10.4

8.8

0.0

e9/l

1.67

21864

102232

(3019550) Sodium [Moles/volume] in Serum or Plasma

54888

292505

2.68

307.65

19.3

13.4

139.5

139.7

mmol/l

80.14

53774

284790

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

21747

80552

2.01

307.65

3.0

2.4

55.0

59.0

u/l

15.41

19951

74554

(3023183) Ammonium ion [Moles/volume] in Plasma

2089

3619

3.60

307.65

3.0

2.6

33.4

34.3

umol/l

0.63

1806

3069

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

55552

313788

2.05

307.65

12.5

9.2

28.0

26.4

u/l

26.75

54000

303415

(3021601) Nitrite [Presence] in Urine by Test strip

28316

138776

1.46

307.65

5.4

4.5

0.0

estimate

0.06

5719

26274

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

15033

27526

4.10

307.65

2.2

1.4

1.6

1.3

248.00

13270

24716

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12158

43119

1.90

307.65

2.7

3.1

2.4

mmol/l

15.46

10483

37851

(3044889) 12 lead EKG panel

38282

192309

1.58

307.65

3.9

3.4

—

(3026782) Osmolality of Urine

12653

49323

1.71

307.65

3.0

2.6

519.4

556.1

mosm/kgh2o

47.36

10774

41969

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6406

20943

1.96

307.65

2.3

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2082

4802

2.70

307.65

1.4

2785.9

2161.4

e6/l

0.13

1688

3916

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

49831

273067

1.65

307.65

15.1

11.3

87.8

83.3

ml/min/173m2

307.65

41136

224230

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

48281

260385

1.66

307.65

6.4

5.1

39.5

39.2

mmol/mol

12.57

45013

243057

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1415

273

32.27

307.65

1.9

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3662

10748

2.14

307.65

4.3

24.2

24.1

mmol/l

0.53

3246

9739

(3000764) Benzodiazepines [Presence] in Urine

6255

9331

4.44

307.65

3.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

14725

57128

1.75

307.65

4.4

3.6

1.0

kg/l

0.39

1845

9102

(3027008) Opiates [Presence] in Urine

6240

9471

4.36

307.65

2.9

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5258

16600

2.02

307.65

2.9

3.5

4.4

4.5

pmol/l

8.78

4550

15075

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

21641

96253

1.58

307.65

4.0

3.1

45.5

55.7

ng/l

0.76

13678

60735

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7356

25615

1.85

307.65

1.9

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2726

7465

2.28

299.86

2.3

576.3

501.2

ug/l

0.34

2529

6993

(40768797) Stomach Pathology biopsy report

8947

36181

1.59

296.30

1.3

1.2

—

(3042936) Bacteria identified in Isolate by Culture

8962

36281

1.59

295.36

2.2

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

15992

73233

1.45

294.69

4.7

3.6

0.0

estimate

5.88

5526

25331

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1476

2976

3.07

293.34

1.6

—

(3016502) Oxygen saturation in Arterial blood

6413

23898

1.71

291.30

8.1

7.7

95.3

96.0

11.09

6214

22961

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7861

30943

1.63

290.02

7.8

6.2

—

(3002385) Erythrocyte distribution width [Ratio]

45093

247339

1.44

287.23

21.2

14.2

13.7

13.6

12.23

44279

242075

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2474

6661

2.31

282.51

1.4

283.2

272.3

ug/g

1.23

1366

3906

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13043

57967

1.47

277.53

1.7

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10717

45916

1.51

271.96

1.3

9.8

12.0

u/ml

1.98

3778

18679

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4086

13546

1.90

271.74

1.6

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

11356

49382

1.49

267.80

1.7

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3705

11992

1.94

264.17

2.4

2.2

5713.1

6062.4

u/l

0.23

1174

5199

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9216

38515

1.54

261.09

2.1

29.5

29.8

4.37

8920

37410

(3000494) Fungus identified in Specimen by Culture

7689

30844

1.59

260.16

1.5

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

1868

4658

2.49

251.19

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

5651

21336

1.67

241.76

8.0

7.6

8.6

9.8

mmol/l

29.90

5374

20377

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5850

22313

1.66

240.76

8.5

8.1

122.9

121.7

g/l

4.43

5670

21470

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3908

13294

1.84

239.02

1.8

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

14739

68871

1.40

231.43

3.0

2.9

1085.3

1309.1

ng/l

6.96

12079

58806

(3019060) Gas panel - Arterial blood

4235

14912

1.78

231.38

5.2

4.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15244

71743

1.39

229.04

1.7

1.6

1.3

mmol/l

113.33

13024

60462

(3009214) Lutropin [Units/volume] in Serum or Plasma

2737

8397

2.03

225.70

1.4

9.3

9.8

u/l

1.16

2161

7044

(21494755) Public health laboratory ask at order entry panel

3679

37689

0.57

225.49

1.3

—

(3022313) Gas panel - Capillary blood

3180

10299

1.93

225.28

3.8

3.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3280

10737

1.91

225.17

1.1

9.2

8.6

u/ml

0.03

165

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5226

19707

1.67

223.64

1.2

113.8

150.7

iu/ml

7.81

1747

7790

(3013512) EKG study

15671

74474

1.38

220.33

4.0

3.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4111

14563

1.77

219.66

7.0

7.1

24.9

24.7

mmol/l

1.89

4063

14454

(3019225) pH of Specimen

6147

24313

1.60

217.57

4.2

4.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1460

3459

2.61

217.23

1.6

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

13766

64172

1.40

216.48

5.0

4.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4013

14206

1.77

214.74

1.4

1.3

24.4

28.0

iu/l

9.38

3307

12486

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

738

1149

3.94

213.19

1.7

1.2

—

(4010399)

4958

18774

1.66

208.09

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

17841

87182

1.35

207.48

2.6

2.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

223

20.95

207.37

1.4

1.0

2.0

—

mmol/l

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4815

18143

1.67

205.79

3.9

89.4

90.6

ng/l

0.29

4151

15839

(3003181) Sodium [Moles/volume] in Urine

1402

3364

2.57

203.39

1.5

1.4

58.7

65.3

mmol/l

6.13

1059

2727

(3005719) IgG [Mass/volume] in Serum or Plasma

5163

19894

1.63

202.22

2.4

2.7

10.3

10.7

g/l

6.47

4648

18302

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5634

22313

1.59

197.10

1.5

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1578

4074

2.39

196.78

1.4

1.3

23.2

26.9

u/l

4.04

1244

3447

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2775

8978

1.92

196.54

3.9

3.5

24.8

mmol/l

0.67

2615

8302

(3012516) Albumin [Mass/volume] in Urine

15820

76462

1.35

194.89

3.4

3.3

401.6

411.7

mg/l

0.09

10099

48306

(3027945) Reticulocytes/100 erythrocytes in Blood

6550

26936

1.54

194.40

2.5

1.8

1.7

5.39

5714

24126

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2392

7396

2.01

192.54

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2408

7467

2.00

192.29

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

2409

7492

2.00

190.80

1.2

—

(3020891) Body temperature

2729

8894

1.91

189.00

5.6

4.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

16489

80507

1.34

188.61

4.2

4.0

10.4

8.7

mg/mmol

2.86

10420

51176

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3102

10565

1.83

187.60

3.4

2.7

1.6

1.2

44.98

3087

10510

(40761535) Cells panel - Urine sediment

5176

20348

1.60

186.13

3.9

3.3

—

(3008295) Osmolality of Serum or Plasma

938

1911

3.02

182.92

1.6

1.4

281.9

279.7

mosm/kgh2o

1.63

688

1522

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

213

+∞

181.25

6.8

0.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4002

14827

1.69

181.20

9.5

9.1

1.6

1.3

32.31

3985

14730

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

37476

205119

1.30

181.06

3.5

3.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3992

14819

1.68

179.37

9.6

9.3

0.7

0.31

3976

14737

(3014007) Fractional oxyhemoglobin in Arterial blood

4009

14930

1.68

177.94

9.6

9.3

93.4

94.2

14.18

3997

14883

(3023410) Appearance of Cerebral spinal fluid

999

2147

2.86

177.83

1.6

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3898

14412

1.69

177.70

8.0

6.7

24.8

24.5

mmol/l

3.83

3678

13351

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3020

10390

1.81

176.54

3.4

2.7

0.7

0.33

2896

9979

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4001

14947

1.67

175.41

1.1

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

223

101

13.48

174.40

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5058

20079

1.58

173.99

2.5

2.2

6.6

7.5

ug/l

1.85

4269

17808

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

572

857

4.09

173.50

1.0

35.7

34.5

ng/l

0.28

396

589

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

570

855

4.09

172.64

1.0

805.4

818.4

ng/l

0.21

398

569

(3018405) Lactate [Moles/volume] in Arterial blood

2398

7717

1.93

172.06

4.6

3.9

1.4

1.3

mmol/l

1.30

2372

7572

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

567

851

4.08

171.61

1.0

251.4

332.9

ng/l

1.13

404

594

(3004119) Hemoglobin [Mass/volume] in Venous blood

3795

14087

1.68

170.22

3.7

3.3

130.5

129.5

g/l

1.85

3694

13772

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

21220

108563

1.29

168.47

4.4

3.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3432

12477

1.71

165.96

9.4

9.6

24.3

mmol/l

0.18

3152

11743

(3025941) Bacteria identified in Stool by Culture

4181

16022

1.63

165.81

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1672

4769

2.17

165.58

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1671

4767

2.17

165.41

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

13657

65944

1.34

163.61

2.5

2.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5047

20306

1.56

163.32

4.1

3.7

1.2

mmol/l

1.98

4352

17827

(3052851) Hemolysis interference index of Serum or Plasma

2279

7336

1.93

163.26

3.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

557

861

3.96

162.44

1.9

1.3

2225877.0

1834484.1

iu/ml

0.20

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2658

9023

1.83

161.89

1.3

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2749

9439

1.81

161.39

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2996

10642

1.75

156.94

1.3

1.2

0.5

1.0

u/ml

2.14

263

909

(3007566) Smooth muscle Ab [Titer] in Serum

2197

7180

1.89

150.29

1.2

1.3

105.8

130.8

titre

0.63

189

663

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

51147

294918

1.38

148.54

5.1

4.5

2.8

mmol/l

1.78

47415

274946

(3028026) IgM [Mass/volume] in Serum or Plasma

3968

15453

1.60

146.74

1.8

1.9

1.3

g/l

0.16

3593

14178

(1616796) Gas panel - Central venous blood

1706

5145

2.05

146.37

3.8

3.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3494

32876

0.62

146.34

1.6

1.7

—

(3007461) Platelets [#/volume] in Blood

56741

333936

1.63

146.22

26.6

17.2

260.4

252.1

e9/l

162.56

55592

325358

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5143

21272

1.52

145.97

2.6

2.1

12.3

12.6

nmol/l

1.60

4451

19232

(3010421) pH of Blood

1948

6173

1.95

145.79

4.4

3.5

7.4

10.60

1661

5237

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1957

6217

1.95

145.42

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

7528

33571

1.42

145.18

1.8

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1851

5793

1.97

143.49

2.1

1.8

190.1

199.3

pmol/l

2.79

1725

5548

(3013139) Helicobacter pylori Ag [Presence] in Stool

4546

18388

1.55

142.73

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

7116

31527

1.42

142.06

19.8

23.7

1.3

inr

4.86

949

4817

(3043409) Potassium [Moles/volume] in Arterial blood

2048

6664

1.90

141.82

4.9

4.1

3.8

3.9

mmol/l

5.60

1933

6288

(3035941) MCH [Entitic mass]

56749

334273

1.62

140.18

26.5

17.1

30.2

0.29

56095

329953

(1761868) Lipid panel - Serum or Plasma

15890

115412

0.78

139.68

2.9

2.6

—

(3024731) MCV [Entitic volume]

56751

334319

1.61

139.51

26.5

17.1

90.7

90.6

7.22

56092

329983

(3026361) Erythrocytes [#/volume] in Blood

56753

334357

1.61

139.00

26.6

17.1

4.5

e12/l

57.87

55475

324918

(3010813) Leukocytes [#/volume] in Blood

56759

334434

1.61

138.29

26.7

17.2

6.9

6.6

e9/l

144.89

55492

324964

(3034770) Mitochondria Ab [Titer] in Serum

2137

7130

1.85

137.05

1.2

711.7

1025.8

titre

1.09

219

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

25324

134613

1.25

136.89

4.2

3.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4592

18787

1.53

136.64

2.4

23.6

23.5

au/ml

0.03

198

1293

(3000963) Hemoglobin [Mass/volume] in Blood

56756

334502

1.61

136.37

26.8

17.2

135.2

136.5

g/l

83.60

56101

330220

(3027315) Oxygen [Partial pressure] in Blood

1718

5378

1.97

133.00

4.6

3.6

8.8

8.7

kpa

0.66

1670

5270

(3012501) Base excess in Blood by calculation

1708

5339

1.97

132.76

4.5

3.6

2.5

2.4

mmol/l

0.11

1197

3548

(3013290) Carbon dioxide [Partial pressure] in Blood

1708

5341

1.97

132.62

4.5

3.6

5.1

5.0

kpa

8.22

1660

5233

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4236

17165

1.54

131.45

1.3

49.6

50.2

au/ml

0.04

122

767

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1804

5778

1.93

130.77

3.1

2.9

24.7

24.5

mmol/l

1.08

1612

5050

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

50355

290776

1.33

130.38

4.7

4.1

4.7

mmol/l

17.29

46904

272741

(3017181) Myelocytes/100 leukocytes in Blood

5317

22696

1.47

128.45

4.2

4.1

0.9

1.0

1.40

1429

6139

(3016650) Hepatitis A virus Ab [Presence] in Serum

1446

4305

2.07

128.24

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

989

2506

2.42

128.15

1.5

1.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

176

11.54

127.49

1.1

1.2

49.5

37.6

mg/l

2.22

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2413

8569

1.74

125.93

2.0

1.7

39.1

41.0

nmol/l

2.75

2345

8398

(3004716) Salmonella sp identified in Stool by Organism specific culture

3759

15072

1.55

121.93

1.3

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

48413

278780

1.29

119.33

4.1

3.7

1.4

1.3

mmol/l

307.65

44502

259387

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

815

1949

2.57

118.89

1.7

2.1

19.4

18.8

nmol/l

0.98

754

1875

(3028626) Oxygen [Partial pressure] in Capillary blood

1641

5261

1.92

118.52

2.9

2.8

8.4

8.3

kpa

1.73

1534

4869

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

49938

288855

1.31

117.92

4.6

4.0

1.4

1.5

mmol/l

250.41

46263

269909

(3002179) Metamyelocytes/100 leukocytes in Blood

4854

20682

1.47

117.81

3.9

0.6

0.7

1.06

1021

4484

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

861

2135

2.47

116.73

1.7

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

4715

20014

1.47

116.59

2.4

2.7

72.8

69.2

e9/l

7.49

3473

15144

(3020961) Endomysium IgA Ab [Titer] in Serum

3450

13704

1.56

116.42

1.1

171.8

193.8

titre

0.16

392

(3021440) Promyelocytes/100 leukocytes in Blood

5035

21691

1.45

115.29

4.3

4.1

0.1

0.74

1303

5747

(3024928) Oxygen saturation in Venous blood

1524

4836

1.94

113.37

3.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5825

25859

1.41

113.06

4.1

3.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4656

19863

1.46

112.00

2.2

2.7

66.7

g/l

0.10

4177

18244

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1390

4288

2.00

111.97

1.1

—

(3025159) Blasts/100 leukocytes in Blood

4781

20521

1.45

111.41

4.3

4.1

0.0

0.3

4.50

1112

4869

(3027273) Bicarbonate [Moles/volume] in Venous blood

2897

11168

1.61

110.74

3.9

3.3

25.4

25.2

mmol/l

0.99

2788

10843

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1112

3164

2.16

110.58

2.0

1.7

4333.3

3200.0

titre

0.35

125

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2698

10226

1.63

110.39

4.4

3.8

51.3

47.5

11.15

2658

10118

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6264

50286

0.73

109.37

2.7

2.9

0.6

0.8

ug/l

15.06

4241

31467

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8998

68423

0.76

106.93

3.9

4.1

21.4

22.0

3.23

3609

31944

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1800

6175

1.80

105.31

1.2

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

4282

18186

1.47

105.09

1.3

253.1

233.5

u/ml

0.29

3903

16904

(3035637) Corticotropin [Mass/volume] in Plasma

1051

3016

2.14

102.33

1.5

1.6

—

(3017509) Phencyclidine [Presence] in Urine

207

195

6.48

101.44

2.3

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

445

827

3.29

100.56

1.4

1.5

548.3

769.9

mu/l

0.81

414

794

(1002224) Polysomnography panel

3050

12176

1.55

100.26

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

451

848

3.25

100.11

1.4

1.5

73.6

72.7

0.58

420

815

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2355

22254

0.63

98.08

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2254

8408

1.66

97.92

1.8

1.7

1.2

g/l

5.30

2138

8017

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2200

8159

1.66

97.72

1.8

1.7

0.2

g/l

0.44

2080

7752

(40767503) Oxygen content in Capillary blood by calculation

1523

5081

1.85

97.39

2.7

2.3

16.8

16.5

1.18

779

2621

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

789

2077

2.33

94.15

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

14254

73287

1.24

94.00

2.5

2.6

2751.1

4316.8

umol/l

6.25

12157

64630

(3028271) Lactate [Moles/volume] in Capillary blood

1188

3695

1.98

93.50

2.2

1.7

1.8

1.7

mmol/l

1.25

1163

3602

(3022145) Colonoscopy Study observation

6707

31346

1.34

93.50

1.3

1.4

—

(3021901) Oxygen saturation in Capillary blood

1314

4251

1.90

92.29

2.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2458

9548

1.59

90.69

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2625

10362

1.57

90.45

1.6

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

117

118.86

90.29

1.4

1.0

508.5

785.4

nmol/l

—

117

(3004588) Protein electrophoresis panel - Serum or Plasma

3794

16197

1.45

90.12

2.1

2.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6330

29499

1.34

89.67

3.6

4.5

231.5

244.3

u/l

10.03

5918

28104

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

940

2723

2.12

89.40

1.3

38.2

25.1

nmol/l

0.79

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2747

11040

1.54

87.37

1.7

1.6

3.6

3.4

mg/l

0.82

2190

7281

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1092

3412

1.96

84.85

1.3

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

639

1603

2.44

84.66

3.2

33.9

25.7

mu/l

3.41

596

1515

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

817

2310

2.17

82.56

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1577

5597

1.73

82.09

1.4

1.3

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

33.50

81.15

1.8

1.0

262.4

170.7

nmol/l

—

(3008898) HLA-B27 [Presence]

2530

10160

1.54

80.63

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

981

3008

2.00

80.34

2.1

1.6

89.8

90.2

1.10

965

2965

(3016038) Potassium [Moles/volume] in Urine

536

1266

2.59

80.26

1.3

1.2

31.2

35.2

mmol/l

3.19

445

1101

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1315

4459

1.81

79.80

1.5

1.4

0.4

nmol/l

1.00

1018

3509

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3165

13366

1.47

79.19

10.3

9.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

745

2064

2.21

79.09

1.2

37.3

46.4

mg/l

4.37

625

1725

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2303

9113

1.56

78.34

2.1

2.0

2.3

ug/l

0.48

2036

8106

(3026389) Candida sp identified in Specimen by Organism specific culture

1154

3797

1.87

77.00

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

679

1833

2.27

76.61

1.3

1.2

2.0

2.1

mmol/l

0.38

626

1712

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2439

9842

1.53

75.97

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

354

682

3.17

75.80

2.9

2.8

29.4

27.9

umol/l

1.01

252

534

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

716

1993

2.20

75.18

1.1

246.4

278.7

mg/l

2.29

621

1759

(3029634) Reagin Ab [Titer] in Serum by VDRL

1183

3986

1.82

73.28

2.4

2.0

6.8

5.6

titre

0.25

105

(3036489) Thrombin time

2503

10235

1.51

73.26

2.1

2.0

21.2

21.4

1.10

2157

8842

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12009

85329

0.82

72.94

4.2

4.7

2.2

3.0

ug/l

3.75

10600

77511

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2140

8495

1.55

71.70

1.9

1.8

—

(4027681)

592

1553

2.33

71.30

1.2

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6973

33912

1.28

71.25

1.8

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

34.00

70.82

1.8

1.2

276.3

213.7

nmol/l

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

669

1860

2.20

70.47

1.1

735.2

291.3

mg/l

0.50

597

1684

(3037121) Protein [Mass/volume] in Urine

2187

8760

1.54

70.38

3.2

0.3

g/l

1.44

939

3940

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

400

870

2.81

69.94

2.7

2.3

55.0

51.6

umol/l

1.28

329

725

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2652

11092

1.48

69.48

1.7

1.8

1.5

g/l

0.20

2290

9505

(3009542) Hematocrit [Volume Fraction] of Blood

47724

278317

1.21

69.44

19.2

12.4

39.9

40.2

14.86

33881

213016

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

687

1957

2.15

68.23

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1944

7641

1.57

67.98

1.3

30.0

37.3

u/ml

0.55

486

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2713

11471

1.46

67.22

1.4

1.6

13.3

14.6

u/ml

0.15

343

(43055514) Macroprolactin [Presence] in Serum or Plasma

326

645

3.09

66.98

1.3

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1534

5736

1.64

65.82

2.2

2.1

132.2

130.9

g/l

1.06

1128

4162

(3012920) Ethanol [Mass/volume] in Serum or Plasma

34.32

65.65

1.5

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6711

32798

1.28

65.50

4.5

4.3

30.5

32.4

37.01

4931

22927

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1059

3571

1.82

65.45

1.3

0.1

0.3

nmol/l

3.25

206

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

535

1400

2.34

64.84

1.3

1.2

5.0

5.2

umol/l

0.33

482

1311

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2736

11688

1.44

64.18

1.9

2.0

39.9

39.4

u/l

0.63

2452

10462

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1501

5633

1.64

63.49

1.2

41.3

43.6

u/ml

0.19

129

574

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1443

5392

1.64

62.07

1.3

270.1

255.1

u/ml

1.07

957

3436

(40761536) Microorganisms panel - Urine sediment

5075

24080

1.31

61.95

4.6

3.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1048

3589

1.79

61.60

1.3

1.0

1.3

nmol/l

0.22

1007

3468

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

476

1212

2.40

61.26

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1513

5752

1.62

60.78

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

486

1258

2.36

60.37

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2488

10563

1.45

60.24

2.2

1.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

512

1362

2.30

59.86

1.1

1.5

6.2

nmol/l

2.75

280

(3039443) Prostate specific Ag panel - Serum or Plasma

450

5949

0.46

59.59

1.4

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1388

5190

1.64

59.55

2.6

1.9

0.9

0.8

nmol/l

3.88

1148

4406

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2176

9022

1.48

59.41

1.6

321.3

296.8

titre

0.12

378

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

362

827

2.67

57.95

1.3

1.4

13.4

15.3

pmol/l

6.37

293

713

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

955

3241

1.81

57.85

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1916

7783

1.51

57.71

2.2

2.5

0.7

0.9

g/l

1.04

1632

6754

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2280

9599

1.46

57.62

2.0

1.8

—

(3019230) Fractional oxyhemoglobin in Venous blood

1152

4135

1.71

57.61

3.5

3.1

64.4

65.5

0.86

1145

4119

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

914

3083

1.82

56.48

7.0

6.1

11.3

11.4

mg/l

0.45

834

2849

(3013005) Retinol [Moles/volume] in Serum or Plasma

397

965

2.51

56.33

1.8

1.7

2.0

umol/l

0.09

365

905

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1761

7078

1.53

55.70

2.0

2.2

38.3

37.8

g/l

2.36

1504

6140

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1719

6881

1.54

55.39

1.8

1.9

9.2

20.6

iu/l

0.58

597

2631

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1611

6363

1.56

55.10

2.1

2.3

0.0

g/l

0.82

1441

5854

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

697

2170

1.97

54.84

1.4

1.3

1.5

1.4

nmol/l

1.70

643

1954

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1719

6899

1.53

54.73

2.0

2.3

0.0

g/l

1.09

1548

6371

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1837

7481

1.51

54.66

1.9

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1239

4603

1.65

54.52

1.7

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3023

13519

1.38

54.51

2.4

—

(3017732) Neutrophils [#/volume] in Blood

4156

19520

1.32

54.27

3.1

2.4

4.1

e9/l

0.23

3150

15519

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

599

1776

2.06

53.84

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

596

1765

2.06

53.74

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2070

8676

1.47

53.49

2.0

2.3

3.0

3.1

g/l

1.65

1603

6793

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

379

925

2.50

53.36

1.8

1.7

28.4

29.5

umol/l

1.23

366

889

(3024980) IgG subclass 4 [Mass/volume] in Serum

1179

4356

1.66

53.00

1.5

1.6

0.7

0.8

g/l

2.21

896

3271

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

19.62

52.85

1.1

1.0

—

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9692

50332

1.20

52.84

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

448

1190

2.30

52.63

1.2

1.3

59.1

66.4

0.65

150

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1490

5845

1.56

52.51

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1581

6288

1.54

52.44

2.1

2.3

0.0

g/l

0.00

1435

5839

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1479

5800

1.57

52.19

1.5

1.4

16.3

21.3

u/ml

0.83

114

(3041096) Erythrocytes [Presence] in Urine by Automated

14563

78430

1.17

52.05

3.7

2.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2170

9230

1.45

51.94

2.0

2.3

7.3

7.4

g/l

1.30

1642

6942

(3047181) Lactate [Moles/volume] in Blood

1869

7722

1.49

51.87

6.5

5.6

1.4

1.3

mmol/l

3.09

1659

6826

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2167

9220

1.45

51.79

2.0

2.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

509

1438

2.16

51.73

1.5

1.4

6.0

5.9

u/l

0.07

412

1212

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

954

3353

1.74

51.43

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2042

8605

1.46

51.31

2.0

2.3

9.9

10.3

g/l

4.39

1689

7250

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1484

5860

1.55

50.81

1.5

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2158

9210

1.44

50.73

2.0

2.3

3.8

g/l

0.13

1584

6586

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1741

7134

1.50

50.29

1.3

6.8

8.9

u/ml

0.63

224

1165

(3040151) Glucose [Moles/volume] in Capillary blood

794

2663

1.82

50.02

9.4

5.2

7.4

7.2

mmol/l

0.61

641

2172

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

988

3541

1.71

49.72

1.1

1.5

g/l

0.31

887

3230

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1765

7277

1.49

49.48

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

345

835

2.52

49.45

2.6

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

918

3232

1.74

49.21

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

927

3273

1.73

49.20

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

434

1172

2.26

49.14

2.2

2.1

17.4

28.5

umol/l

1.08

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

918

3236

1.74

49.00

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1908

8009

1.46

48.90

2.5

185.6

185.2

0.06

1797

7597

(3005988) Vibrio sp identified in Specimen by Organism specific culture

918

3241

1.73

48.74

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

925

3280

1.73

48.37

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1368

5380

1.56

47.69

1.5

1.4

112.8

111.4

u/ml

0.13

313

1250

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2051

8775

1.44

47.56

2.2

93.5

92.3

1.33

1904

8164

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1706

7045

1.49

47.45

1.3

6.1

6.6

u/ml

0.10

137

782

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1423

5660

1.54

47.19

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

593

1844

1.97

46.90

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

448

1252

2.19

46.81

1.3

1.2

278.2

340.5

u/l

0.58

416

1165

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1957

8328

1.44

46.70

1.1

4.0

5.3

u/ml

0.81

196

1198

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

422

1152

2.24

46.63

1.6

16.2

5.7

nmol/l

0.38

341

963

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

442

1232

2.19

46.48

1.9

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4234

20343

1.29

46.41

2.8

154.2

194.5

ng/l

7.48

3778

18502

(3011985) Renin [Units/volume] in Plasma

979

3569

1.68

46.32

1.5

1.6

63.4

60.1

mu/l

0.22

861

3223

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1754

7334

1.47

45.85

1.4

1.5

17.9

13.3

iu/ml

0.43

193

(40768804) Tissue Pathology biopsy report

21185

118140

1.14

45.23

2.1

2.0

—

(3014271) Vancomycin [Susceptibility]

360

933

2.36

44.76

3.2

2.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

429

1202

2.18

44.58

1.7

1.4

19.6

28.1

umol/l

7.53

402

1145

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1934

8293

1.43

44.29

2.8

2.5

3.6

g/l

0.09

1846

7922

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2272

10026

1.39

44.24

5.7

4.8

1.9

1.6

18.96

2131

9388

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

486

1440

2.06

43.87

1.1

1.0

1.1

u/l

0.64

195

664

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

300

722

2.54

43.57

1.2

21.5

20.2

0.08

135

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1122

4307

1.60

43.38

1.1

863.4

548.9

iu/ml

0.14

254

986

(3000492) Spirometry study

5744

28835

1.23

43.14

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

325

819

2.42

42.95

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1419

5764

1.51

42.74

1.2

3.2

5.9

u/ml

1.11

470

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2267

10074

1.38

42.33

1.3

221.8

224.6

miu/ml

0.12

862

5020

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

540

1693

1.95

41.79

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4480

21948

1.26

41.74

2.7

2.5

70.3

66.8

ml/min/173m2

5.97

1825

8445

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

330

850

2.37

41.64

1.8

2.4

0.9

1.1

ug/l

1.00

304

804

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

899

3302

1.67

41.41

1.3

1.4

334.7

284.8

pmol/l

2.33

714

2567

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

540

1704

1.94

41.03

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1219

4840

1.54

40.78

3.3

3.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

844

3061

1.69

40.76

2.2

1.9

22.0

26.7

mg/l

1.80

244

787

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1394

5704

1.50

40.56

1.2

13.6

14.8

u/ml

0.04

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1080

4192

1.58

39.89

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1881

8180

1.41

39.84

2.7

2.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

797

2868

1.70

39.63

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

246

564

2.66

39.33

1.4

1.3

17.1

16.8

umol/l

0.45

215

502

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1105

4334

1.56

39.03

1.5

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2199

9874

1.37

38.50

5.9

4.9

0.9

0.14

2068

9244

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1032

4009

1.58

38.00

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

241

558

2.63

37.84

1.4

1.2

132.0

126.2

nmol/l

0.16

163

427

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1354

5605

1.48

37.25

5.7

5.6

5020.6

1139.8

iu/ml

0.47

157

847

(3044242) Glucose [Moles/volume] in Arterial blood

352

984

2.18

36.89

2.2

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

868

3263

1.63

36.60

1.6

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

535

1750

1.87

36.60

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

345

963

2.19

36.30

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

566

1895

1.82

36.02

2.7

2.5

807.7

703.5

e6/l

0.86

218

803

(3045716) Anion gap in Serum or Plasma

353

999

2.16

35.92

2.2

2.5

9.3

9.1

mmol/l

0.38

268

702

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

+∞

35.72

3.0

0.0

2.5

—

ug/l

—

(4062490)

752

2744

1.68

35.58

1.4

—

(3025130) Human papilloma virus identified in Specimen

1040

4116

1.55

35.35

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1718

7516

1.40

35.17

1.9

2.1

11.1

10.7

mg/l

0.66

1599

7043

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2920

13870

1.30

34.70

2.9

2.6

0.3

e6/l

0.61

2845

13462

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

716

2596

1.69

34.70

1.6

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

429

1328

1.97

34.53

1.6

1.3

1.2

nmol/l

0.77

318

1069

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

519

1715

1.85

34.45

1.2

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

746

2743

1.66

34.31

1.4

0.4

g/l

2.46

531

1884

(3028192) IgG subclass 2 [Mass/volume] in Serum

746

2744

1.66

34.27

1.4

2.9

3.0

g/l

0.99

528

1882

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1659

7250

1.40

34.18

3.6

3.1

1.5

mg/l

0.52

1535

6705

(3027135) IgG subclass 1 [Mass/volume] in Serum

745

2747

1.66

33.91

1.4

6.5

6.9

g/l

2.11

527

1882

(3045414) Leukocytes [Presence] in Urine

2635

12390

1.31

33.77

1.9

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

187

403

2.83

33.57

1.6

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

128

217

3.59

33.45

2.3

3.5

41.1

41.8

umol/l

0.13

112

177

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1074

4350

1.51

32.87

1.2

3.6

3.8

u/ml

0.22

481

1973

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

936

3683

1.55

32.68

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

543

1851

1.79

32.66

1.3

1.4

12.0

12.1

umol/l

0.16

498

1789

(3003338) MCHC [Mass/volume]

44013

259143

1.13

31.72

23.4

14.6

332.5

332.9

g/l

14.20

43682

257262

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1984

9036

1.35

31.71

1.7

1.6

7.7

4.0

iu/ml

0.21

399

1849

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

276

744

2.26

31.61

1.2

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

53.59

31.46

1.3

1.2

168.4

177.5

nmol/l

—

(3017569) Oxygen content in Arterial blood

334

976

2.09

31.44

2.3

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

620

2222

1.70

31.41

2.9

2.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1028

4191

1.50

30.54

1.9

2.2

6.5

6.4

umol/l

0.05

754

3074

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

181

405

2.72

30.43

1.5

1.3

61.0

106.5

ng/l

1.28

104

283

(40768800) Prostate Pathology biopsy report

515

5300

0.59

30.29

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1218

5146

1.45

30.26

1.2

77.3

147.5

titre

1.43

110

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

818

3181

1.57

30.10

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

465

1554

1.83

29.87

2.2

2.0

98.1

97.2

0.21

435

1442

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

486

1647

1.80

29.85

2.0

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

199

475

2.55

29.59

1.2

—

(3019977) pH of Arterial blood

385

1213

1.94

29.57

3.0

2.4

7.4

0.59

113

451

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

189

441

2.61

29.38

1.3

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

782

3027

1.58

29.36

1.6

33.9

35.0

iu/ml

0.05

138

(3039162) Centromere protein B Ab [Units/volume] in Serum

873

3466

1.54

29.34

1.2

50.1

51.5

u/ml

0.05

234

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1026

4219

1.49

29.25

2.8

2.7

1725.8

7295.1

u/ml

0.93

237

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

730

2783

1.60

29.20

1.2

57.1

63.4

u/l

1.75

497

1878

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1058

4382

1.48

29.12

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

621

2.33

29.00

3.1

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

621

2.33

29.00

3.1

2.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1021

4213

1.48

28.63

1.1

120.5

118.1

1.45

922

3815

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

220

562

2.39

28.47

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

213

536

2.42

28.46

1.1

6.2

7.2

mg/g

1.52

201

513

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1282

5539

1.42

28.24

1.5

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1085

4545

1.46

28.21

1.2

2.7

3.8

u/ml

1.83

361

1590

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

435

1460

1.82

27.62

1.3

—

(3011048) Pyruvate [Moles/volume] in Blood

104

4.57

27.57

1.4

1.5

87.1

70.9

umol/l

2.71

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

205

516

2.42

27.40

1.7

2.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

575

2098

1.67

27.35

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

575

2098

1.67

27.35

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

575

2098

1.67

27.35

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

854

3428

1.52

27.34

1.5

1.4

—

(40768443) Skin Pathology biopsy report

2535

12198

1.28

27.17

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

224

593

2.30

26.84

1.1

—

(4306422)

1043

4381

1.46

26.76

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

636

2396

1.62

26.75

1.7

1.8

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1287

5626

1.40

26.54

3.4

3.3

4.1

4.0

e9/l

1.02

1281

5616

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1687

7705

1.34

26.50

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

223

593

2.29

26.46

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

623

2342

1.62

26.43

2.3

2.0

42.9

40.0

0.92

304

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

211

549

2.34

26.28

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

223

595

2.28

26.26

1.1

—

(3001556) Androgen free Index in Serum or Plasma

129

259

3.03

26.25

1.4

1.2

—

(44813793)

555

2034

1.67

26.00

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

253

719

2.15

25.67

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

293

884

2.02

25.48

1.3

1.2

110.5

111.2

0.15

264

790

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

223

605

2.25

25.30

1.1

—

(3011412) CD3 cells [#/volume] in Blood

673

2609

1.58

25.19

2.5

2.3

1.3

1.1

e9/l

2.68

385

1556

(3051651) Icteric interference index of Serum or Plasma

422

1445

1.78

25.16

4.1

3.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

590

2216

1.63

25.15

1.2

157.1

199.6

titre

0.67

100

385

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

388

1295

1.83

25.14

1.1

8.8

10.8

u/ml

0.54

217

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

512

1854

1.69

25.11

2.6

2.4

526.3

526.0

e6/l

0.00

427

1549

(3000475) Leukocytes [#/volume] in Synovial fluid

1405

6292

1.37

25.08

1.6

12079.7

12686.9

e6/l

0.20

996

4626

(44790049)

703

2757

1.56

25.04

1.6

1.5

—

(44790047)

703

2758

1.56

25.00

1.6

1.5

—

(44806118)

703

2758

1.56

25.00

1.6

1.5

—

(44790048)

703

2759

1.56

24.96

1.6

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1383

6185

1.37

24.90

2.4

2.5

117.9

102.2

ug/min

0.53

797

3775

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1774

8243

1.32

24.77

3.5

3.1

0.3

u/ml

0.49

1006

4684

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

587

2211

1.62

24.75

1.2

269.5

196.8

titre

0.28

(40759836) Histone Ab [Presence] in Serum by Immunoblot

561

2089

1.64

24.75

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

562

2095

1.64

24.69

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

969

4077

1.45

24.69

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

159

372

2.60

24.69

1.8

1.2

mmol/l

0.29

151

355

(3019420) Tryptase [Mass/volume] in Serum or Plasma

429

1485

1.76

24.68

1.4

1.5

6.7

8.5

ug/l

2.07

387

1341

(3039000) Anion gap in Blood

1238

5448

1.39

24.59

8.0

6.6

11.3

11.1

mmol/l

0.74

1128

4894

(3018572) Chloride [Moles/volume] in Blood

1238

5449

1.39

24.56

8.0

6.6

104.9

105.3

mmol/l

2.23

1128

4896

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

310

971

1.95

24.33

1.3

1.2

0.3

g/l

1.40

249

771

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

560

2094

1.63

24.32

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

563

2110

1.63

24.23

1.2

—

(3023419) Bacteria identified in Sputum by Culture

752

3017

1.52

24.20

2.4

2.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

985

4175

1.44

24.15

1.4

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

563

2112

1.63

24.14

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

563

2115

1.63

24.01

1.2

—

(4034850)

1824

8558

1.31

23.76

11.5

8.6

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

149

344

2.64

23.76

1.9

1.8

1.2

mmol/l

0.00

142

328

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

315

1002

1.92

23.66

3.1

2.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

118

242

2.97

23.25

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

116

237

2.98

23.00

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

543

2045

1.62

22.96

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

421

1483

1.73

22.85

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

169

3.39

22.76

2.1

1.9

1.3

umol/l

0.67

149

(4146454)

673

2676

1.54

22.60

2.7

2.8

—

(3004616) Nuclear Ab [Presence] in Serum

814

3370

1.48

22.57

1.4

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

489

1802

1.66

22.52

2.7

2.5

0.2

e9/l

1.02

421

1552

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

424

1510

1.71

22.16

2.9

2.7

39.4

39.2

0.06

131

531

(3035320) C reactive protein [Mass/volume] in Body fluid

515

1932

1.63

22.14

2.8

2.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

412

1458

1.72

22.03

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

149

358

2.54

22.02

1.4

1.3

0.3

nmol/l

0.03

114

248

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

425

1520

1.71

21.89

1.2

1.3

26.5

22.9

u/l

0.65

365

1319

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

677

2718

1.52

21.78

1.7

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

856

3607

1.45

21.71

2.5

2.8

174.1

625.8

u/ml

1.26

818

3430

(3032057) Clostridioides difficile [Presence] in Stool

173

450

2.34

21.67

1.8

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

203

567

2.18

21.59

1.1

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

209

594

2.14

21.32

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

661

2655

1.52

21.23

3.7

3.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

434

1575

1.68

21.21

1.2

99.0

85.1

u/l

1.55

383

1385

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1779

8467

1.29

20.84

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

427

1551

1.68

20.81

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

349

1201

1.77

20.59

38.3

34.9

7.4

7.3

ug/l

0.29

324

1089

(3034860) Kappa light chains.free [Mass/volume] in Serum

1613

7593

1.30

20.55

2.9

3.5

47.3

71.9

mg/l

1.53

1278

6184

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1611

7583

1.30

20.54

2.9

3.4

35.2

43.8

mg/l

1.87

1273

6188

(3044941) Cell count panel - Synovial fluid

929

4017

1.41

20.51

1.4

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

160

3.31

20.42

1.5

1.3

14.7

12.7

pmol/l

0.20

133

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

331

1127

1.79

20.24

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

331

1127

1.79

20.24

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1563

7353

1.30

20.02

2.8

3.4

6.2

4.3

ratio

0.21

138

561

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

579

2290

1.54

19.99

4.0

3.9

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

744

3112

1.46

19.66

1.1

96.3

96.1

0.06

692

2923

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

129

308

2.55

19.38

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

485

1856

1.59

19.32

1.5

—

(3022621) pH of Urine by Test strip

3481

17974

1.19

19.00

3.2

2.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

174

490

2.16

18.24

1.1

0.8

3.6

umol/24h

0.49

251

(4268621)

712

2998

1.45

18.22

2.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

152

406

2.28

18.05

1.4

1.5

5.5

7.0

nmol/l

0.82

142

390

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

709

2995

1.45

17.85

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

473

1835

1.57

17.84

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

941

4180

1.38

17.81

2.9

3.4

1.4

0.09

722

3243

(3008757) Leukocyte morphology finding [Identifier] in Blood

651

2711

1.47

17.66

3.3

3.7

—

(1175426) CD3 cells/100 lymphocytes in Blood

523

2084

1.53

17.54

2.1

2.0

74.7

72.4

3.34

498

2007

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

142

374

2.31

17.42

1.1

1.0

81.5

82.4

ug/l

0.07

119

301

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

139

363

2.33

17.38

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

551

4919

0.68

17.20

3.5

2.3

13.2

13.1

0.88

545

4855

(3028717) Thiamine [Mass/volume] in Blood

100

224

2.72

17.03

1.1

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

104

238

2.66

17.02

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

150

412

2.22

16.74

1.1

1.2

2.6

6.9

u/ml

0.43

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

449

1748

1.57

16.72

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

283

977

1.77

16.64

2.5

2.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

313

1114

1.71

16.56

1.8

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

154

3.08

16.50

1.6

49.0

48.4

umol/l

0.05

154

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

483

1919

1.54

16.45

2.3

1.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

511

2059

1.51

16.32

2.1

1.9

13.0

14.6

1.71

254

924

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1459

7004

1.27

16.05

1.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

256

868

1.80

16.00

2.0

2.1

60.1

58.6

ug/l

0.09

251

845

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

218

2.68

15.97

2.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1113

8781

0.77

15.89

1.8

—

(3006270) Folate [Moles/volume] in Blood

500

2020

1.51

15.80

1.2

1.1

373.2

377.7

nmol/l

0.18

429

1738

(3029075) Extractable nuclear Ab panel - Serum

232

767

1.84

15.73

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

236

2.58

15.48

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

342

1271

1.64

15.45

1.2

1.1

3.9

iu/ml

0.03

104

(3021788) Differential panel - Synovial fluid

1052

4867

1.32

15.32

1.5

—

(3002619) Bacteria identified in Specimen by Culture

167

497

2.05

15.32

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

446

1771

1.54

15.28

2.8

3.4

110.6

133.1

nmol/l

0.78

431

1750

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

416

1628

1.56

15.20

1.6

5.8

6.9

u/l

0.51

189

812

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

349

1310

1.62

15.17

1.6

1.8

134.9

139.9

0.65

323

1237

(3000060) B lymphocytes [#/volume] in Blood

222

735

1.84

15.01

2.3

1.9

151.6

935.3

e6/l

1.26

128

366

(3014051) Protein [Presence] in Urine by Test strip

1277

6082

1.28

15.00

2.2

2.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

270

949

1.73

14.99

1.6

1.9

154.9

164.2

0.76

253

896

(3017354) Segmented neutrophils/100 leukocytes in Blood

601

2550

1.44

14.89

2.8

3.4

58.4

0.02

374

1649

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

613

2611

1.43

14.87

3.6

5.0

48.3

115.8

u/ml

4.21

156

844

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

184

574

1.95

14.86

1.3

1.2

453.3

283.0

pmol/l

1.00

121

438

(3006245) CD3-CD19+ cells/100 cells in Blood

284

1017

1.70

14.77

2.2

2.1

9.0

10.4

1.13

266

937

(3042631) Mycobacterium sp identified in Specimen

744

3284

1.38

14.73

2.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

135

376

2.19

14.65

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1320

6332

1.27

14.65

1.1

1.5

1.8

u/ml

0.45

589

2498

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

279

997

1.71

14.63

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

118

3.25

14.52

1.2

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

234

2.52

14.42

2.1

2.6

0.9

1.4

mmol/l

1.63

165

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

284

1026

1.69

14.32

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

165

2.84

14.27

2.5

3.2

2.1

2.3

mg/l

0.67

140

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

105

266

2.40

14.12

2.0

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1193

5681

1.28

14.06

1.1

5.2

5.8

u/ml

0.68

649

2904

(3037756) Immunofixation for Serum or Plasma

1067

5008

1.30

14.05

1.5

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

284

1032

1.68

14.03

1.1

967.5

465.5

ng/l

0.28

251

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

259

918

1.72

14.01

1.1

94.2

90.3

1.08

104

461

(3045424) Erythrocytes [Presence] in Urine

1025

4794

1.31

13.86

1.5

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

194

632

1.87

13.84

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

159

2.83

13.67

1.1

18.0

13.7

nmol/l

0.57

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

745

3336

1.36

13.55

1.2

1.1

2.1

2.2

iu/ml

0.03

(40760888) Immunoglobulin light chains.free panel - Serum

1191

5698

1.28

13.54

2.9

3.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

275

1002

1.67

13.48

2.2

2.0

28.4

29.5

0.67

259

946

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

923

7295

0.77

13.43

1.4

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

868

3986

1.33

13.38

1.2

—

(3020491) Glucose [Moles/volume] in Blood

494

2064

1.46

13.33

1.9

1.7

7.1

6.6

mmol/l

2.40

368

1506

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

352

1369

1.57

13.29

8.9

5.0

662.7

4369.2

u/ml

0.68

110

223

(3010503) CD19 cells [#/volume] in Blood

408

1643

1.51

13.19

2.7

2.5

0.2

0.4

e9/l

0.65

394

1607

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

367

1448

1.55

13.03

1.2

1.3

489.4

455.3

titre

0.04

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

687

3061

1.37

12.92

1.1

—

(3028433) Virus identified in Specimen by Culture

237

841

1.72

12.82

1.2

—

(3042733) HLA Ab [Presence] in Serum

256

929

1.68

12.77

4.8

5.2

—

(37021550) Renin [Units/volume] in Plasma --upright

161

508

1.93

12.67

1.3

82.1

66.0

mu/l

0.40

120

388

(3001964) Herpes simplex virus Ag [Presence] in Specimen

224

785

1.74

12.66

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

316

1213

1.59

12.65

1.1

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

518

2207

1.43

12.64

1.2

55.1

50.7

u/ml

0.09

111

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

507

2152

1.44

12.63

1.2

71.3

66.7

u/ml

0.11

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

257

937

1.67

12.60

1.1

116.0

107.0

2.81

237

846

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

357

1412

1.54

12.56

1.2

1.3

57.3

72.0

titre

0.41

119

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.53

12.45

1.6

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1124

5405

1.27

12.31

1.1

0.9

1.1

u/ml

0.62

512

2255

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

506

2159

1.43

12.27

1.2

52.0

44.2

u/ml

0.29

167

(3022493) Free Hemoglobin [Mass/volume] in Plasma

290

1102

1.60

12.12

4.0

5.5

778.6

3509.7

mg/l

2.00

205

784

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

411

1699

1.47

11.78

1.3

1.5

24.7

23.2

u/ml

0.21

306

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

156

1698

0.56

11.70

1.2

1.3

—

(4024509)

558

2444

1.39

11.70

1.7

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

371

1504

1.50

11.69

2.4

2.6

866.4

1127.2

u/ml

1.13

366

1486

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

246

906

1.65

11.66

1.1

96.6

91.0

1.15

100

463

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

164

2.64

11.58

1.1

7.7

9.5

u/l

0.42

164

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

487

2087

1.42

11.56

1.3

0.8

1.4

u/ml

1.18

218

893

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

119

351

2.06

11.32

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

560

2469

1.38

11.31

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

229

835

1.67

11.29

3.2

3.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

146

466

1.91

11.18

1.1

1.5

4.5

u/ml

1.48

109

321

(3051339) Copper [Moles/volume] in Blood

113

2.96

11.05

1.5

1.2

16.9

16.6

umol/l

0.15

(3024869) Neuronal Ab [Presence] in Serum

136

426

1.94

11.01

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

326

1304

1.52

10.98

1.0

1.1

100.3

96.6

1.29

256

1042

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

107

308

2.12

10.85

1.3

1.4

43.1

54.4

1.21

162

(3045683) HLA typing for celiac disease panel - Blood or Tissue

435

1852

1.43

10.75

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

250

946

1.61

10.70

1.3

1.2

0.9

0.5

g/l

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

477

2070

1.41

10.61

1.2

12.5

9.3

u/ml

0.22

139

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

137

437

1.91

10.54

1.2

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

333

1355

1.50

10.38

1.1

85.7

82.4

u/l

0.24

251

1094

(3036603) Volume of Urine

433

1855

1.42

10.36

1.6

1.7

1972.4

1919.6

0.19

430

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

173

598

1.76

10.36

1.1

1.3

111.8

106.4

1.41

158

568

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

898

4296

1.28

10.35

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1093

5352

1.25

10.34

1.1

2.2

u/ml

0.02

277

1301

(3000034) Microalbumin [Mass/volume] in Urine

525

2328

1.38

10.29

3.1

3.0

44.4

54.6

mg/l

0.50

378

1663

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

245

932

1.60

10.29

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

107

315

2.07

10.28

1.4

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

661

3038

1.33

10.27

2.8

3.3

5.2

7.6

nmol/l

0.64

637

2951

(4015189)

177

619

1.74

10.19

2.7

2.1

—

(3044927) Protein electrophoresis panel - Urine

517

2291

1.38

10.18

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

332

1356

1.49

10.18

1.1

24.5

21.8

u/l

0.23

242

1063

(3006576) Bicarbonate [Moles/volume] in Blood

223

832

1.63

10.13

5.8

6.6

25.2

25.0

mmol/l

0.32

208

745

(3012494) Peanut IgE Ab [Units/volume] in Serum

224

837

1.63

10.12

1.1

1.5

5.1

u/ml

1.67

130

459

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1104

5427

1.24

10.10

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1729

12392

0.84

10.06

2.0

1.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

423

1817

1.42

10.00

1.1

1.2

1.1

ratio

0.53

132

664

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

324

1322

1.49

9.99

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

324

1322

1.49

9.99

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

324

1322

1.49

9.99

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

545

2444

1.36

9.98

1.3

1.4

95472.3

117252.6

e6/l

0.38

376

1687

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

165

569

1.77

9.98

1.1

1.2

93.3

88.3

0.52

177

(40768441) Liver Pathology biopsy report

453

1972

1.40

9.93

1.5

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

203

745

1.66

9.84

1.6

9.3

8.9

ug/l

0.74

203

745

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

233

2195

0.64

9.77

1.2

1.3

1.5

g/l

0.01

103

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

323

1324

1.49

9.75

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

732

3441

1.30

9.70

2.4

2.5

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

119

2.76

9.67

1.6

1.5

195.3

173.7

ug/g

0.38

105

(3020876) Protein [Mass/time] in 24 hour Urine

475

2100

1.38

9.53

1.8

2.0

1.1

g/24h

0.03

124

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

956

4656

1.25

9.53

1.1

19.8

11.5

au/ml

1.13

346

(3010375) cycloSPORINE [Mass/volume] in Blood

297

1203

1.50

9.51

27.7

27.8

119.6

115.9

ug/l

0.22

235

1018

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

135

445

1.85

9.47

2.6

44.0

74.8

mg/l

0.95

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

687

3219

1.30

9.35

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

159

557

1.74

9.16

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

142

481

1.80

9.16

1.4

1.3

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

4.16

9.09

1.0

0.0

0.1

u/ml

0.45

(3027231) Wheat IgE Ab [Units/volume] in Serum

160

563

1.73

9.08

1.1

1.0

1.2

2.2

u/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1302

9474

0.83

9.06

1.4

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

840

4058

1.26

9.00

1.2

1.3

31.6

35.8

u/l

0.51

735

3548

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

256

1017

1.53

9.00

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

256

1018

1.53

8.96

2.0

2.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

161

573

1.71

8.80

1.1

78.3

77.8

0.03

170

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

258

1033

1.52

8.77

2.0

2.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

126

2.61

8.74

1.6

2.2

10.2

8.6

nmol/l

0.07

120

(3049717) Cytology report of Urine Cyto stain

1801

9423

1.17

8.53

2.3

2.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

342

1461

1.43

8.43

1.6

1.7

2.0

2.6

u/field

1.11

255

1048

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

419

1856

1.38

8.38

1.1

8.0

8.4

iu/ml

0.10

516

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

201

2.21

8.36

1.7

1.6

2.4

1.9

mg/l

0.27

122

(3003129) Base excess in Capillary blood by calculation

164

596

1.68

8.34

1.7

1.1

0.4

mmol/l

1.28

155

564

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

291

1.99

8.31

1.0

0.0

0.2

u/ml

1.83

171

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

315

1331

1.44

8.24

1.6

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

180

673

1.63

8.22

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

102

2.74

8.20

1.2

1.1

719.9

317.2

u/l

0.67

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

321

1366

1.43

8.10

1.1

1.2

24.7

12.6

u/ml

0.41

128

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

110

2.66

8.07

1.6

1.5

0.0

0.2

u/l

1.30

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

135

469

1.75

8.07

2.7

2.4

7.1

7.5

mmol/l

0.52

281

(3020123) Porphyrins [Interpretation] in Serum or Plasma

140

2.43

7.95

1.2

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

118

396

1.81

7.91

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

108

2.65

7.87

1.2

1.0

0.9

umol/24h

0.06

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

315

1345

1.43

7.82

1.6

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

220

2.10

7.74

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

882

4363

1.23

7.74

1.3

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

208

2.14

7.74

3.5

4.5

36.2

43.8

g/mol

0.32

188

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

275

1148

1.46

7.70

1.1

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.37

7.69

1.0

1.2

205.3

397.5

pmol/l

0.97

(3010838) Calcium [Moles/time] in 24 hour Urine

307

1312

1.43

7.60

1.6

5.4

5.8

mmol/24h

0.16

103

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

348

1521

1.39

7.59

1.5

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

101

327

1.88

7.59

1.7

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2781

15123

1.12

7.54

2.8

3.3

55.5

47.8

u/ml

0.30

2667

14646

(3005011) Chlamydia sp Ab [Titer] in Serum

107

354

1.84

7.53

1.7

1.6

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

133

2.43

7.49

1.1

41.2

102.2

u/l

0.68

105

(3011841) English Walnut IgE Ab [Units/volume] in Serum

244

2.02

7.46

1.0

0.2

1.3

u/ml

1.37

180

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2745

18632

0.89

7.39

1.4

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

112

2.55

7.37

1.0

0.2

0.1

u/ml

0.48

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

183

708

1.57

7.33

2.2

1.8

8147.4

12279.8

e6/l

0.34

373

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

152

562

1.65

7.31

1.5

1.6

0.4

ug/l

0.38

101

378

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

581

1.64

7.29

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.39

7.29

1.0

0.2

0.8

u/ml

0.87

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

166

2.24

7.24

1.3

1.5

44.0

37.6

0.48

115

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

159

2.26

7.16

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

282

1201

1.43

7.15

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

117

405

1.76

7.14

1.8

1.7

77.5

51.1

pmol/l

0.30

341

(3002256) Pathology report gross observation

6619

37622

1.08

7.13

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

100

330

1.84

7.12

1.1

—

(3004451) EKG impression Narrative

278

1182

1.43

7.12

1.3

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

116

401

1.76

7.11

1.1

2.4

8.5

pmol/l

0.72

(3024932) HLA-DR beta [Type]

226

926

1.49

7.00

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

134

2.36

6.98

1.1

1.0

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

1.4

1.6

mg/l

0.16

114

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

3.7

4.1

mg/l

0.16

121

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

2.1

2.2

mg/l

0.06

139

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

1.9

2.1

mg/l

0.17

136

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

2.2

mg/l

0.01

123

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

0.7

1.0

mg/l

0.54

125

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

1.9

1.8

mg/l

0.06

114

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

2.1

2.9

mg/l

0.57

138

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

197

2.10

6.96

1.7

1.5

2.4

2.3

mg/l

0.03

129

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

110

377

1.78

6.95

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

251

1.96

6.94

1.1

1.8

3.2

umol/24h

0.48

251

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

146

2.29

6.92

1.3

1.5

12.5

13.1

0.05

109

(3052592) Norovirus Ag [Presence] in Stool

124

441

1.71

6.91

1.2

1.3

—

(3024263) Appearance of Synovial fluid

309

1349

1.40

6.84

1.6

1.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

310

1355

1.39

6.82

1.1

1703.6

1457.1

miu/ml

2.86

310

1355

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

270

1.92

6.80

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

249

1.96

6.78

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

299

1301

1.40

6.76

1.6

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

239

998

1.46

6.76

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

123

440

1.70

6.73

2.9

2.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

463

1.68

6.72

5.0

5.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

200

808

1.51

6.65

2.3

1.8

3730.1

3462.2

e6/l

0.03

131

550

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

123

2.38

6.54

1.3

0.6

1.8

1.60

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

223

925

1.47

6.54

1.9

1.6

59900.4

21054.2

u/ml

0.38

117

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

608

4609

0.80

6.52

1.2

—

(3024471) HLA-A [Type]

228

951

1.46

6.50

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

355

1601

1.35

6.47

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

139

2.28

6.47

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

143

2.26

6.46

1.1

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

175

2.12

6.43

1.0

0.2

1.3

u/ml

1.03

109

(3051593) INR in Capillary blood by Coagulation assay

251

1072

1.43

6.33

5.6

10.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

273

1.87

6.32

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.72

6.29

1.0

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

220

918

1.46

6.28

1.1

1.0

10.0

11.7

u/ml

0.23

118

(40757373) Influenza virus identified in Isolate

123

451

1.66

6.18

1.7

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

228

1.95

6.17

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

183

2.06

6.11

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

297

1316

1.37

6.08

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

130

487

1.63

6.03

1.4

24.0

39.2

g/l

0.72

392

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1301

6834

1.16

6.00

1.3

1.2

—

(3012565) Volume of 24 hour Urine

309

1382

1.36

5.98

2.0

2.2

1961.8

2002.3

0.23

279

1248

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

328

1.76

5.93

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.94

5.91

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

528

2550

1.26

5.87

1.5

1.6

29.6

32.7

1.09

315

1600

(3016750) Collection duration of Urine

336

1529

1.34

5.83

2.2

510.9

496.9

min

1.82

247

1157

(3013945) Hepatitis B virus e Ab [Presence] in Serum

154

2.13

5.82

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

892

4555

1.19

5.80

1.1

2.5

2.9

u/ml

0.71

313

2399

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

278

1229

1.38

5.80

2.2

23.2

246.0

ug/l

1.80

260

1175

(3016031) Almond IgE Ab [Units/volume] in Serum

183

2.03

5.78

1.0

0.5

u/ml

0.03

(3000012) Reticulocyte production index

304

1365

1.36

5.76

1.3

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

147

2.15

5.73

1.3

—

(3016228) CD19 cells/100 cells in Blood

254

1109

1.40

5.71

2.1

1.9

9.2

8.5

0.48

246

1087

(3036071) Salmonella sp Ab [Titer] in Serum

222

947

1.43

5.69

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

101

2.41

5.67

1.0

0.2

0.0

u/ml

0.76

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

904

4632

1.19

5.67

1.1

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

248

1082

1.40

5.61

2.6

2.7

168.4

141.6

au/ml

0.33

141

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

596

2935

1.24

5.60

1.3

1.4

12.4

11.8

mmol/l

0.83

201

595

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

107

389

1.67

5.60

1.1

0.2

0.3

u/ml

0.18

246

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.10

5.57

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.14

5.55

3.2

3.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

141

2.16

5.55

1.1

1.2

u/field

0.11

(3034426) Prothrombin time (PT)

228

983

1.41

5.53

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

275

1225

1.37

5.50

2.2

2.1

70.0

82.5

ug/min

0.20

269

(3027974) Hepatitis B virus e Ag [Presence] in Serum

162

2.07

5.49

1.4

1.5

—

(40762365) Oxygen content in Arterial blood by calculation

105

383

1.67

5.44

4.1

2.8

14.5

14.8

ml/dl

0.45

361

(21494814) CD8 cells/100 lymphocytes in Specimen

248

1089

1.39

5.42

2.1

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

272

1214

1.36

5.39

1.3

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

214

917

1.42

5.38

1.5

1.4

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

253

1.83

5.38

1.0

0.3

1.6

u/ml

0.88

185

(40768446) Kidney Pathology biopsy report

257

1139

1.37

5.32

1.7

1.6

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

156

2.07

5.31

1.0

0.2

2.5

u/ml

1.47

123

(3006442) Creatine [Moles/volume] in Serum or Plasma

412

1958

1.28

5.27

1.8

1.4

62.2

72.1

umol/l

1.71

175

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

271

1214

1.36

5.26

1.3

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.54

5.23

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

265

1186

1.36

5.18

3.2

7.9

8.2

mg/l

0.20

207

945

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.11

5.15

1.4

1.3

66.5

55.6

e6/l

0.07

(3013762) Body weight Measured

2.34

5.08

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

228

1.84

5.03

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

254

1136

1.36

5.00

3.7

3.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

452

2188

1.26

5.00

1.8

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

194

1.91

4.98

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.45

4.88

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.57

4.88

1.0

207.5

174.2

pmol/l

0.34

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

675

3422

1.20

4.83

1.5

1.6

58.0

55.7

0.74

412

2208

(40761995) Spermatozoa Progressive [#/volume] in Semen

950

0.63

4.79

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

949

0.63

4.77

6.1

6.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

137

552

1.51

4.76

1.6

1.3

11.7

14.4

g/l

2.68

441

(44806071)

365

1.63

4.75

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

6.08

4.74

1.1

1.0

17.7

13.9

umol/l

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

160

1.98

4.68

1.3

1.2

33.6

21.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

190

1.89

4.67

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

162

680

1.45

4.62

2.2

1.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

361

1721

1.28

4.58

1.4

5.7

5.5

mmol/l

1.78

340

1628

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

162

1.95

4.54

1.0

17.3

16.5

u/ml

0.04

134

(3012898) Urea [Moles/volume] in Urine

259

1.74

4.52

1.5

153.6

174.8

mmol/l

0.75

232

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

218

970

1.37

4.49

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

353

1683

1.28

4.48

1.4

12.2

12.8

u/l

0.96

344

1626

(3038177) Helicobacter pylori Ab [Presence] in Serum

968

5096

1.16

4.46

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

107

416

1.57

4.39

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

160

1.94

4.38

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

179

774

1.41

4.37

1.4

1.5

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.04

4.36

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

180

780

1.41

4.35

1.4

52.6

53.3

0.09

150

674

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

166

1.91

4.26

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2699

17789

0.92

4.13

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

580

2955

1.20

4.02

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.96

4.00

1.0

1.1

2.4

3.0

mmol/l

0.37

(40763480) Human metapneumovirus Ag [Presence] in Specimen

115

2.06

3.98

1.3

1.4

—

(3000330) Specific gravity of Urine by Test strip

2366

13223

1.09

3.95

3.7

3.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

493

2485

1.21

3.85

1.4

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

142

1.93

3.84

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

240

1.70

3.84

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

876

4635

1.15

3.83

1.1

6.0

4.2

u/ml

0.90

364

1793

(40759632) Porphyrins [Mass/mass] in Stool

3.77

3.83

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

192

862

1.36

3.81

2.0

1.8

—

(3018133) Calcium [Moles/volume] in Urine

100

397

1.53

3.81

1.5

1.9

2.5

2.8

mmol/l

0.61

355

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5367

34421

0.94

3.79

1.5

1.4

—

(3045177) Copper [Moles/volume] in Urine

2.96

3.79

1.1

0.2

0.6

umol/l

—

(3020393) Adenovirus Ag [Presence] in Stool

255

1.67

3.78

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

269

1.65

3.77

1.0

0.4

0.6

u/ml

0.13

152

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.77

3.76

1.2

2.8

3.3

1.9

mu/l

0.54

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

375

1.54

3.72

2.2

2.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

144

1.90

3.71

2.0

1.5

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

3.14

3.69

1.0

0.1

0.3

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1829

12189

0.91

3.64

1.4

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.20

3.60

1.0

1.1

0.2

g/l

0.41

(3044007) Cell count panel - Peritoneal fluid

151

659

1.39

3.58

2.2

1.9

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

292

1.61

3.58

1.0

0.9

3.7

u/ml

0.72

159

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

146

1.88

3.57

1.3

1.4

23.8

22.2

mmol/l

0.98

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

204

1.73

3.57

1.5

1.3

1.5

ml/s/173m2

0.20

129

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

383

1899

1.23

3.56

1.9

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

100

2.07

3.53

1.3

1.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

284

1.61

3.52

1.0

0.2

0.4

u/ml

0.49

154

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.39

3.47

7.5

8.9

—

(3008037) Lactate [Moles/volume] in Venous blood

1006

5414

1.13

3.47

3.7

2.9

1.6

1.5

mmol/l

0.14

984

5299

(3004775) Volume in Urine collected for unspecified duration

411

2060

1.22

3.45

2.3

711.0

672.2

0.95

297

1432

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

102

417

1.49

3.43

5.5

5.0

50.9

45.0

ug/min

0.33

323

(3023430) Cat dander IgE Ab [Units/volume] in Serum

821

4363

1.15

3.43

1.1

6.6

4.6

u/ml

0.95

371

1781

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

127

1.92

3.40

13.2

9.4

575.6

237.0

e6/l

0.44

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

417

2097

1.21

3.40

1.9

2.3

u/field

0.01

209

908

(21494890) Protein electrophoresis panel - 24 hour Urine

508

2602

1.19

3.40

1.8

2.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

380

1.51

3.35

1.4

1.5

7.0

275922.2

nmol/l

2.56

328

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

148

653

1.38

3.33

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

148

653

1.38

3.33

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

148

653

1.38

3.33

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

148

653

1.38

3.33

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

135

587

1.40

3.31

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

146

1.83

3.29

6.3

4.7

—

(3017704) Immunofixation for Urine

273

1317

1.26

3.28

1.5

1.7

—

(3042628) Porphyrins [Moles/volume] in Urine

6.08

3.16

1.1

1.0

—

(3049233) Organic acids panel - Urine

6.08

3.16

1.1

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

2.61

3.09

1.1

1.0

66.4

60.2

mu/l

0.05

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1227

6734

1.11

3.07

1.4

110.2

125.8

pmol/l

0.75

1194

6573

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

207

975

1.29

3.04

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

133

1.83

3.00

1.2

1.4

2071.8

978.1

u/l

0.30

123

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.46

2.93

1.2

1.0

2.1

2.9

0.82

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

248

1201

1.26

2.93

3.3

3.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

145

653

1.35

2.92

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

161

737

1.33

2.92

1.8

1.7

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.27

2.88

7.7

8.5

48.8

42.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

354

1.48

2.87

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

2.77

2.86

1.0

8238.4

13895.8

ng/l

—

(3025549) Creatine [Moles/time] in 24 hour Urine

204

1.64

2.86

1.6

1.4

—

15.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

411

1.44

2.80

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

278

1372

1.23

2.80

1.2

1.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.84

2.80

3.1

2.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4646

26931

1.05

2.79

3.4

4.2

23.2

24.5

ug/l

0.11

3697

21382

(3011325) HIV 1+2 Ab [Presence] in Serum

142

1.76

2.73

1.1

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.03

2.73

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

410

2939

0.85

2.72

1.5

1.6

8.0

7.5

mmol/l

3.37

246

1715

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1674

9388

1.09

2.71

3.0

3.6

346.8

1512.3

u/ml

3.05

1400

8103

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.08

2.71

1.2

1.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.08

2.71

1.0

—

(3042951) Complement C1q Ab [Units/volume] in Serum

130

1.78

2.65

1.2

11.4

20.0

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

163

760

1.31

2.64

1.2

39.1

40.5

g/l

0.66

410

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.03

2.64

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

181

1.65

2.62

1.2

121.7

112.9

ug/l

0.13

116

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

563

2981

1.15

2.59

1.8

2.0

27.9

24.4

ug/l

0.39

551

2922

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

156

727

1.31

2.55

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

758

0.71

2.53

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

116

520

1.36

2.47

2.3

2.2

—

(40768793) Breast Pathology biopsy report

1143

6332

1.10

2.46

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

268

1341

1.22

2.42

1.4

1.5

3.8

4.3

0.18

311

(3003694) ABO and Rh group [Type] in Blood

14609

86894

1.03

2.41

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

263

1.50

2.41

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.88

2.41

1.1

1.0

u/field

0.31

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

303

1.47

2.40

2.5

2.2

0.7

0.6

u/field

0.22

303

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

103

1.83

2.39

5.2

5.8

15.8

17.9

mmol/l

1.20

(3013293) Extractable nuclear Ab [Presence] in Serum

420

1.39

2.38

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

113

508

1.35

2.38

5.1

6.6

64.4

72.1

2.11

405

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

214

0.48

2.37

1.1

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

558

2982

1.14

2.29

2.8

2.2

105.4

105.6

mmol/l

0.48

558

2953

(36303858) Crystals [Presence] in Urine

2.51

2.27

1.2

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

558

2984

1.14

2.27

2.8

2.2

4.0

mmol/l

1.13

558

2955

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

327

1.43

2.27

1.7

1.6

1.7

mg/l

0.25

272

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

267

1.48

2.26

1.1

—

(40768795) Lymph node Pathology biopsy report

412

2903

0.86

2.26

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

119

1.74

2.24

1.1

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

377

2671

0.86

2.23

1.4

1.5

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.19

2.23

1.0

3.3

0.4

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

955

5276

1.10

2.22

2.9

3.5

652.6

885.2

u/ml

0.30

853

4811

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

691

3756

1.12

2.18

1.0

0.6

0.4

u/ml

0.49

166

749

(3017461) Flecainide [Moles/volume] in Serum or Plasma

153

1.63

2.16

1.5

1.6

0.7

umol/l

0.11

117

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1119

6238

1.09

2.16

1.8

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

843

4637

1.11

2.15

1.3

3.0

3.7

ug/l

3.04

741

4164

(3000219) Insulin receptor Ab [Presence] in Serum

6.08

2.12

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.47

2.07

1.1

—

(3019174) dRVVT (LA screen)

253

1.47

2.06

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.15

2.04

1.1

—

(3024316) Viscosity of Plasma

123

1.68

2.03

1.8

1.6

mpas

0.17

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

112

518

1.32

2.01

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

241

1220

1.20

2.00

1.2

1.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.23

1.94

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

403

0.66

1.94

6.6

1.2

7.8

7.1

mmol/l

0.68

127

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.55

1.93

1.0

52.7

22.1

umol/l

—

(3007147) Virus identified in Stool by Electron microscopy

3.55

1.93

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

218

1098

1.21

1.92

1.9

2.0

9.3

9.6

mg/l

0.28

172

878

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

330

1.38

1.87

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

170

1.54

1.84

1.3

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

337

1.37

1.82

2.3

2.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

225

1.46

1.82

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.88

1.80

2.1

1.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.83

1.77

2.1

1.8

—

(3045142) Bone marrow Pathology biopsy report

434

2986

0.88

1.76

1.3

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.12

1.76

1.1

1.0

41.0

36.4

iu/ml

—

(3007916) DNA double strand Ab [Titer] in Serum

376

1.34

1.76

1.4

1.3

85.7

156.4

titre

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1852

10635

1.06

1.69

1.5

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

317

1.36

1.66

2.4

2.8

—

(3035933) Granulocytes/100 leukocytes in Blood

162

808

1.22

1.63

2.6

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

171

1.49

1.61

1.4

1.3

21.8

16.0

pmol/l

0.39

142

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.82

1.58

1.0

0.1

u/ml

0.07

(3009677) Dengue virus Ab [Presence] in Serum

123

1.58

1.1

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

187

1.46

1.57

2.3

3.0

77.3

391.9

pmol/l

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

182

1.47

1.57

1.0

1.1

11.5

7.1

u/ml

0.55

133

(4211845)

285

1500

1.16

1.57

3.0

2.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.69

1.57

1.1

227.5

279.8

nmol/l

0.87

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

3.80

1.57

1.2

1.0

8.8

0.0

u/l

—

(3038515) Glucose [Moles/volume] in Venous blood

915

5146

1.08

1.54

3.9

3.0

7.5

mmol/l

0.07

895

5051

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

266

1.37

1.50

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

118

577

1.24

1.46

2.6

2.5

—

(3006462) Nitrate [Presence] in Urine

259

1363

1.16

1.46

3.1

2.9

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

362

1.31

1.46

2.6

2.7

63.0

73.5

pmol/l

0.25

317

(3027456) Digoxin [Moles/volume] in Serum or Plasma

756

4232

1.09

1.45

3.2

3.1

0.8

nmol/l

0.35

557

3294

(3009015) Lactate [Moles/volume] in Synovial fluid

273

1.36

1.45

1.1

1.3

5.1

6.4

mmol/l

1.10

131

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

171

870

1.20

1.45

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.38

1.43

1.0

1.1

—

(3034614) HLA Ag [Interpretation]

1.78

1.43

1.4

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

1.39

0.0

1.8

—

(3000285) Sodium [Moles/volume] in Blood

312

1.33

1.39

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

533

2946

1.10

1.37

2.9

2.2

—

(3050794) Legionella sp Ab [Presence] in Serum

240

1.37

1.35

1.1

—

(3025315) Body weight

240

1.37

1.35

5.0

4.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

474

2606

1.11

1.35

3.9

3.6

39.4

50.2

u/ml

0.56

467

2580

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

145

732

1.21

1.35

1.8

2.0

39.4

32.3

u/l

0.24

129

667

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

126

630

1.22

1.30

1.8

2.6

102.0

107.0

ng/l

0.14

310

(44786800) Granulocytes/100 leukocytes in Body fluid

263

1.34

1.29

1.2

1.3

28.6

24.8

0.32

205

(3032641) Amino acids panel - Urine

2.61

1.28

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.17

1.27

1.2

1.1

136.8

144.3

mmol/24h

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

192

1.39

1.25

1.1

30.7

25.5

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

192

1.39

1.25

1.1

14.5

31.8

u/ml

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

137

696

1.20

1.22

1.2

1.3

38.8

40.3

0.16

473

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.97

1.22

2.2

4.2

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

137

1.47

1.21

1.0

1.3

—

438.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

207

0.65

1.21

2.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.03

1.20

1.5

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.62

1.18

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

787

4460

1.07

1.17

1.3

7.3

7.0

mmol/l

1.92

576

3183

(3019768) Coxiella burnetii Ab [Presence] in Serum

164

1.41

1.16

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

144

1.44

1.15

1.1

1.3

—

19339.8

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

283

0.71

1.14

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

116

586

1.20

1.12

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

116

587

1.20

1.11

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

109

549

1.21

1.10

1.3

1.2

44.8

41.9

mg/l

0.03

383

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

116

588

1.20

1.09

1.2

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.11

1.08

1.1

1.0

—

(3041184) Isoniazid [Presence] in Urine

2.11

1.08

2.6

2.9

—

(3037556) Urate [Mass/volume] in Serum or Plasma

148

768

1.17

1.08

1.5

1.3

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.63

1.06

1.1

1.0

0.1

0.2

u/ml

0.37

(3021374) Sirolimus [Mass/volume] in Blood

2.03

1.06

8.8

8.4

7.0

7.7

ug/l

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

152

792

1.17

1.06

1.4

57.0

62.8

1.17

128

647

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.80

1.04

1.1

84.7

97.6

nmol/24h

0.36

(3046861) Legionella sp Ag [Presence] in Urine

142

1.41

1.04

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

102

1.49

1.03

9.8

8.7

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

179

1.36

1.02

1.4

1.3

314.5

325.8

umol/24h

0.14

179

(3036312) Salmon IgE Ab [Units/volume] in Serum

169

1.37

1.01

1.0

1.1

0.3

0.8

u/ml

0.72

120

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.56

1.00

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

324

1784

1.11

0.98

5.8

6.7

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

123

0.59

0.98

1.0

0.1

0.2

u/ml

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.43

0.98

1.3

1.1

35.8

31.3

nmol/24h

—

(3018001) Oat IgE Ab [Units/volume] in Serum

207

1.32

0.97

1.1

1.0

0.3

1.1

u/ml

0.54

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

166

878

1.15

0.97

1.6

1.7

104.7

129.5

au/ml

0.32

106

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

134

1.41

0.97

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

196

1050

1.14

0.96

1.0

—

(40765096) Chromosome analysis panel by Banding

106

764

0.84

0.95

1.1

1.2

—

(3028468) Fragments [Presence] in Blood by Light microscopy

2.28

0.94

1.0

1.9

—

(4133840)

126

893

0.86

0.93

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

222

0.71

0.92

2.3

2.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

494

2784

1.08

0.92

1.5

4814.0

2133.7

e6/l

1.80

365

1981

(3027874) Urate [Moles/volume] in Urine

1.50

0.91

1.0

1.6

8.5

mmol/l

0.52

(4094501)

1329

7725

1.05

0.90

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

332

1844

1.10

0.87

1.4

27.6

32.8

nmol/l

2.70

290

1710

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.52

0.87

3.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

819

5272

0.94

0.87

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

358

1998

1.09

0.86

1.0

1.1

0.6

2.6

u/ml

1.13

134

511

(3020356) Listeria sp identified in Specimen by Organism specific culture

196

1.30

0.85

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

457

2578

1.08

0.85

1.4

1.3

71.4

111.4

pmol/l

0.58

199

751

(3032352) Blasts [#/volume] in Cerebral spinal fluid

278

1.25

0.83

2.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

187

1.30

0.81

3.5

5.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

128

676

1.15

0.81

1.1

1.2

288.0

551.8

titre

—

(3027035) Albumin [Mass/time] in 24 hour Urine

252

1.26

0.80

1.3

136.5

330.6

mg/24h

—

(3002523) Influenza virus A Ag [Presence] in Specimen

821

5267

0.95

0.80

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1599

10099

0.96

0.79

1.4

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

313

1.22

0.79

1.2

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.34

0.79

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.77

0.78

1.1

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.42

0.77

1.3

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.71

0.76

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.17

0.76

1.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.46

0.75

1.1

856.4

4997.6

ng/l

1.86

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.66

0.74

1.9

2.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

142

1.33

0.73

3.9

3.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

153

1.31

0.72

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.77

0.72

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

393

1.18

0.66

1.2

1.3

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

103

1.36

0.64

1.3

1.0

u/field

0.99

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.59

0.63

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

165

0.74

0.63

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.52

0.63

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.52

0.63

1.3

1.2

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.38

0.62

1.1

5.0

5.3

mmol/l

0.13

(3028308) Erythrocytes [#/volume] in Pleural fluid

444

2540

1.06

0.62

1.5

51185.7

53037.0

e6/l

0.04

274

1482

(3032743) Legionella sp IgG Ab [Presence] in Serum

190

1.25

0.62

1.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.57

0.60

1.1

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.59

8.4

6.8

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

114

0.69

0.59

1.0

0.1

0.5

u/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

438

1.15

0.59

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1036

6067

1.04

0.58

4.2

3.1

24.6

26.4

mg/l

0.76

625

3802

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1220

7680

0.97

0.57

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1501

9415

0.97

0.57

1.4

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.34

0.57

1.0

0.1

0.2

u/ml

0.34

(21494567) Legionella sp IgM Ab [Presence] in Serum

198

1.23

0.57

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1124

6599

1.04

0.56

4.9

3.7

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.66

0.56

1.2

3.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.56

0.56

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

1.36

0.55

1.3

1.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

481

1.14

0.55

1.1

1.4

42.4

195.7

titre

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.48

0.54

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

730

4254

1.04

0.54

1.7

1.6

—

(3014891) Appearance of Pleural fluid

283

1.18

0.54

1.8

1.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.56

0.54

1.0

1.1

1104.0

2357.4

titre

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1507

9440

0.97

0.53

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1510

9454

0.97

0.52

1.4

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

104

0.70

0.52

1.0

0.1

1.0

u/ml

—

(4212803)

223

1.20

0.51

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1220

7659

0.97

0.51

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1512

9460

0.97

0.51

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

496

1.13

0.50

2.3

5.7

51.7

53.9

u/l

0.06

199

(3020650) Glucose [Presence] in Urine

127

853

0.91

0.50

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

174

1.22

0.49

1.6

1.7

0.7

0.08

135

(3045788) Cell count panel - Pleural fluid

378

2173

1.06

0.49

1.6

1.5

—

(3015183) Erythrocyte sedimentation rate

255

1661

0.93

0.49

1.2

—

(3022475) Manganese [Moles/volume] in Blood

180

1.22

0.48

1.0

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

253

1.18

0.48

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

401

1.14

0.47

1.8

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

446

0.87

0.47

6.3

7.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

122

0.75

0.46

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

123

679

1.10

0.46

1.4

3.2

2.5

0.51

107

564

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

148

1.23

0.46

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

231

1311

1.07

0.46

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

282

1825

0.94

0.46

1.0

0.5

0.8

u/ml

0.29

222

(3010937) Rubella virus Ab [Presence] in Serum

194

1.19

0.43

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

449

0.88

0.43

5.2

5.4

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.43

0.0

1.2

—

1.8

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.43

0.0

1.7

—

(40758292) HTLV I+II Ab panel - Serum

519

0.89

0.42

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

327

2099

0.95

0.42

1.3

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.35

0.41

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.35

0.41

1.0

—

(44806420)

116

646

1.09

0.39

2.0

2.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

112

623

1.09

0.39

1.4

26.5

20.6

1.31

104

555

(3003434) Protein [Mass/volume] in Pleural fluid

533

3118

1.04

0.38

1.5

34.6

33.2

g/l

1.70

481

2808

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

152

1.20

0.38

2.4

1.9

8.6

17.6

1.63

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

373

0.88

0.38

7.5

8.0

0.3

0.4

umol/l

0.61

343

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

172

976

1.07

0.37

1.1

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.30

0.37

1.0

1.1

69.7

70.4

—

(3022670) pH of Venous cord blood

1.41

0.37

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

443

0.89

0.37

2.4

2.3

4.2

3.9

ug/l

0.11

149

(3001729) Color of Synovial fluid

209

1.16

0.37

1.6

—

(3029612) Listeria sp Ab [Titer] in Serum

1.35

0.36

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

296

1.13

0.35

2.9

1.2

1.3

mg/l

0.04

196

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

199

1.16

0.35

2.3

2.0

48.8

60.4

0.97

132

(43055442) Apixaban [Mass/volume] in Serum or Plasma

314

1.12

0.34

1.4

1.6

104.6

118.2

ug/l

0.44

257

(4281824)

474

2992

0.96

0.33

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

138

1.19

0.32

1.4

1.7

243.0

192.7

ng/l

0.47

119

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

413

0.90

0.32

3.2

3.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1260

7835

0.98

0.32

1.4

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

400

0.90

0.32

1.1

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.26

0.32

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.37

0.32

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.37

0.32

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.37

0.32

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.37

0.32

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.37

0.32

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.37

0.32

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

227

1455

0.95

0.31

1.9

1.8

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

167

1.17

0.31

3.2

3.0

32.0

13.1

2.33

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

162

1.16

0.30

1.8

1.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.35

0.30

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

100

1.22

0.30

1.7

1.2

—

(40758358) Immune stain study

117

1.20

0.30

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

246

1567

0.95

0.28

2.0

3.8

ug/l

0.01

209

1384

(40763590) HLA-DQ beta [Type]

107

1.19

0.27

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

130

1.17

0.26

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

353

2071

1.04

0.26

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

438

1.08

0.26

3.5

2.7

2087.9

1663.9

u/l

0.18

396

(3006598) pH of Arterial cord blood

1.22

0.25

1.0

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.29

0.25

1.1

—

(40760409) HLA-A [Type] by High resolution

108

1.18

0.25

1.0

—

(40760410) HLA-B [Type] by High resolution

108

1.18

0.25

1.0

—

(3012441) Differential panel - Pleural fluid

412

2428

1.03

0.25

1.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

206

1.12

0.24

1.1

4.8

16.7

iu/ml

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

269

1701

0.96

0.24

1.2

1.3

15.7

13.7

u/l

0.55

252

1572

(21494434) Karyotype in Bone marrow

361

2269

0.97

0.23

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.32

0.23

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

109

1.17

0.23

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

116

0.84

0.23

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.81

0.22

1.1

1.3

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.22

0.22

1.2

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

104

1.17

0.22

1.1

1.2

0.1

g/l

0.68

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

5.4

—

(3013862) HLA-DP [Type]

110

1.16

0.21

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.24

0.21

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

612

0.94

0.19

1.2

1.3

329.1

196.7

ug/l

0.27

323

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

210

1.10

0.19

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.22

0.19

1.2

1.3

1.7

2.3

mmol/24h

0.79

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.20

0.18

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

566

0.95

0.18

2.1

1.7

1.8

3.8

ug/l

1.31

344

(3042301) Urate [Moles/volume] in Synovial fluid

1.22

0.17

1.0

448.2

356.5

umol/l

—

(3018291) Platelet Ab [Presence] in Serum

1.22

0.15

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

244

0.92

0.15

1.2

1.5

0.4

0.2

umol/l

0.53

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.81

0.14

2.5

2.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

111

702

0.96

0.13

1.3

—

(40768806) Pleura Pathology biopsy report

410

2448

1.02

0.13

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

356

2125

1.02

0.12

1.3

629.9

447.9

u/l

1.02

334

2024

(4038314)

272

0.94

0.12

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

163

1.08

0.11

1.0

1.1

12.4

u/ml

0.46

(3047189) Immunofixation for 24 hour Urine

187

1166

0.98

0.11

1.7

1.9

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

330

1.05

0.11

1.2

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

302

0.95

0.10

1.3

50.5

296.5

u/l

0.92

214

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

196

0.93

0.10

4.1

5.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.89

0.10

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

147

1.08

0.09

1.0

1.1

0.7

10.5

u/ml

0.48

(3042010) Triglyceride [Moles/volume] in Pleural fluid

344

1.04

0.09

1.2

1.3

1.2

1.5

mmol/l

0.19

217

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

157

0.93

0.08

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

343

2117

0.99

0.08

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.12

0.08

1.4

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.12

0.08

1.4

1.2

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

1.09

0.08

1.3

1.2

85.6

80.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

114

712

0.97

0.08

1.3

4.8

3.3

mmol/l

2.47

106

663

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.11

0.08

6.5

5.5

0.2

mmol/l

0.35

(4035726)

4040

24496

1.00

0.07

1.4

—

(3025577) Chromium [Mass/volume] in Blood

245

1514

0.98

0.07

2.1

2.5

2.4

ug/l

0.09

194

1276

(3041918) Cholesterol [Moles/volume] in Pleural fluid

430

1.03

0.07

1.2

1.7

mmol/l

0.00

258

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

113

1.08

0.07

12.9

13.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

587

0.97

0.07

7.8

8.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

395

1.03

0.06

12.8

5.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

251

1.04

0.06

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

316

1943

0.99

0.05

1.6

1.9

—

(3009871) Measles virus Ab [Titer] in Serum

175

1049

1.01

0.05

1.7

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

392

1.02

0.04

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

351

1.02

0.03

1.3

1.4

11.9

11.7

0.01

178

(3035880) pH of Pleural fluid

210

1266

1.01

0.03

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

325

1989

0.99

0.02

1.0

1.9

2.2

u/ml

0.08

446

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.06

0.02

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

744

4512

1.00

0.02

3.7

3.5

29.5

38.9

u/ml

1.71

715

4358

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

189

1.03

0.02

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

139

0.96

0.02

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

559

1.01

0.02

1.5

1.4

30.2

22.6

1.41

468

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

109

670

0.99

0.02

7.5

8.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

370

2260

1.00

0.02

1.3

6.5

6.3

mmol/l

0.48

335

2110

(3029396) Erythrocyte agglutination [Presence] in Blood

169

1022

1.01

0.01

2.8

3.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.06

0.01

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

540

0.99

0.01

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

215

1.02

0.00

1.1

1.2

18.6

17.5

g/l

0.32

195

(3035082) Kappa light chains [Mass/volume] in Urine

1.03

0.00

1.1

0.0

0.2

g/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

151

1.01

0.00

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.00

0.00

1.1

1.0

0.0

0.1

g/l

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.00

0.00

1.3

1.2

19.9

30.2

mg/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

246

1.01

0.00

1.0

1.1

22.0

20.3

u/l

0.20

161

(3032868) Hemoglobin electrophoresis panel in Blood

285

1.00

0.00

1.5

1.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

354

2157

1.00

0.00

1.8

4.1

3.7

mg/l

0.76

333

2063

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.95

0.00

2.2

1.2

6.4

5.6

mg/l

—

(3048879) Bone marrow aspiration report

124

756

1.00

0.00

1.9

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

125

0.97

0.00

1.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.99

0.00

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

1.1

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.7

—

4.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.89

0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_MOOD_EXMORE – Mood disorders, excluding more controls

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mood disorders, excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints